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i 
ABSTRACT 
 
The increasing pervasiveness of infections caused by multidrug-resistant bacteria 
(MDR) is a major global health issue that has been further exacerbated by the dearth of 
antibiotics developed over the past 40 years. Drug-resistant bacteria have led to 
significant morbidity and mortality, and ever-increasing antibiotic resistance threatens to 
reverse many of the medical advances enabled by antibiotics over the last 40 years. The 
traditional strategy for combating these superbugs involves the development of new 
antibiotics. Yet, only two new classes of antibiotics have been introduced to the clinic 
over the past two decades, and both failed to combat broad spectrum gram-negative 
bacteria. This situation demands alternative strategies to combat drug-resistant superbugs. 
Herein, these dissertation reports the development of potent antibacterials based on 
biomolecule-encapsulated two-dimensional inorganic materials, which combat 
multidrug-resistant bacteria using alternative mechanisms of strong physical interactions 
with bacterial cell membrane. These systems successfully eliminate all members of the 
‘Superbugs’ set of pathogenic bacteria, which are known for developing antibiotic 
resistance, providing an alternative to the limited ‘one bug-one drug’ approach that is 
conventionally used. Furthermore, these systems demonstrate a multimodal antibacterial 
killing mechanism that induces outer membrane destabilization, unregulated ion 
movement across the membranes, induction of oxidative stress, and finally apoptotic-like 
cell death. In addition, a peptide-encapsulation of the two-dimensional material 
successfully eliminated biofilms and persisters at micromolar concentrations. Overall, 
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these novel systems have great potential as next-generation antimicrobial agents for 
eradication of broad spectrum multidrug-resistant bacteria. 
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CHAPTER 1 
Introduction and motivation 
Two-dimensional transition metal dichalcogenides (TMDCs) are a class of 
layered materials, with each planer layer are made up of hexagonal MX2 units and where 
M represents transition metal atom and X represents chalcogen.1-5 Structurally, each 
transition-metal layer (M) is sandwiched between two layers of chalcogen atom (X). 
Based on the arrangement of metal and chalcogen atom, TMDCs exhibits structural 
polymorphism which includes 1H, 2H and 3R crystal phases. TMDCs also exhibit 
extraordinary mechanical, electrical and optical properties, which has led to 
implementation of these materials in a wide range of material-based applications in 
nanoelectronics, photonics, sensing, energy storage and opto-electronics2,3,6. Apart from 
electronic applications, the high surface area, absence of dangling bonds and high 
stability in liquid and air of the TMDCs, have inspired researchers to use them for a wide 
range of biological applications such as drug delivery, biosensing and antibacterial 
systems.7-16 
The design of TMDC-based systems for biological applications involves careful 
engineering of 2D material surfaces using a wide range of biological molecules, which 
will enhance between the material and biological species, without imposing significant 
toxicity to mammalian cell. Until now, most of work in this regard focused on chemical 
based solution-phase processing, followed by covalent or non-covalent functionalization 
of TMDCs using biological relevant molecules.17,18 Chemical treatment-based solution-
phase processing usually involves treatment of TMDCs with strong reducing intercalating 
agents such as n-BuLi, followed by ultrasonication in the presence of biomolecules, 
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which leads to generation of biological molecules functionalized nanosheets. Despite 
successes in the development of TMDC systems for biological applications, the harsh 
treatment and presence of highly toxic lithium ion, hinders its implementation for clinical 
applications. To overcome these problems, researchers have developed alternative 
ultrasonication-based solution-phase processing of TMDCs. In this approach, TMDCs are 
generally ultrasonicated in the presence of aqueous amphiphilic molecule to produce 
biologically molecule encapsulated TMDCs. In these techniques, the amphiphilic 
molecule undergoes intercalation within TMDCs interlayer, leading to weakening of 
interlayer forces, followed by ultrasonication in aqueous solution. The ultrasonication 
creates chaotic shear forces, which in turn lead to the weakening of interlayer force and 
exfoliation of TMDCs. Furthermore, amphiphilic molecules undergo hydrophobic 
interactions with TMDC surfaces and stabilize the nanosheets using electrostatic and 
steric repulsion. Although there are some reports on dispersing TMDCs in biological 
active molecules, such as BSA19, double stranded DNA20, there are still few reports on 
dispersing TMDCs using biological molecules such as peptides, single stranded DNA, 
proteins and aptamers21.  
In this thesis, we report solution-phase processing of TMDCs in the presence of 
short synthetic single-stranded DNA (ssDNA). Unlike previous reports, which focused on 
solution-phase processing of TMDCs using naturally occurring long genomic double 
stranded DNA (2000 bp), herein we report dispersion of TMDCs in the presence short 
20-nucleotide (nt) ssDNA. Also, we characterized the ssDNA-dispersed TMDCs using 
spectroscopic and microscopic techniques, which showed the pristine nature of ssDNA-
dispersed TMDCs. Furthermore, we screened the affinity of different DNA sequences 
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toward the TMDC surface using experimental and computational methods. We studied 
the biocompatibility of these system against human carcinoma cell, HeLa cells. After 
successful determination of biocompatibility, we further demonstrated successful 
eradication of multidrug-resistant bacteria. After successful determination of antibacterial 
activity, we further evaluated the antibacterial mechanism of ssDNA-dispersed TMDCs. 
In another work, we functionalized the TMDC surface with the cationic peptide 
poly-L-lysine and the amphiphilic block copolymer Pluronic F77. The highly positively 
charged poly-L-lysine enables the TMDC system to selectively target bacterial cell walls, 
while Pluronic-F77 stabilizes the system in high salt buffer conditions. This hybrid 
system showed strong electrostatic interactions towards multidrug-resistant bacteria and 
eliminates them through membrane damage. Furthermore, it showed an overall 
multimodal antibacterial action towards bacteria, overcoming the traditional problem of 
antibiotic targeting intracellular targets. The designed systems also successfully 
eradicated hard-to-eliminate biofilms and persisters. Finally, the designed system 
overcame the traditional problem of bacteria undergoing mutation and developing 
resistance, as demonstrated by extended exposure of bacterial cultures to the 
nanomaterial preparation.  
1.1) Structure of dissertations 
The work presented in this thesis demonstrates versatile techniques for 
bionanotechnological interfacing of biologically relevant molecules on the surface 
TMDCs and its implementation for development of novel antibacterial systems.  
 In Chapter 2, I introduce background on two-dimensional materials, crystal 
structure and its mechanical and optical properties. I also describe the biological 
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applications of two-dimensional materials, followed by a detailed discussion on the 
antibacterial applications of two-dimensional materials. 
In Chapter 3, I present generalizable techniques for dispersing TMDCs using 
short synthetic single-stranded DNA, followed by studies of DNA sequence dependence, 
characterization of DNA-dispersed TMDCs, in vitro antibacterial activity evaluations of 
these designed systems, and mechanistic evaluation of the system. 
In chapter 4, I present a novel TMDC/poly-L-lysine system that targets the 
bacterial cell membrane of multidrug-resistant bacteria and eliminates them. 
Furthermore, these systems demonstrate a multimodal mechanism of action against 
bacteria. Also, this chapter presents a detailed mechanistic study of antibacterial action of 
these designed systems. 
In chapter 5, I conclude my thesis summarizing the work and discussing the future 
applications of these designed systems. 
 
 
 
 
 
 
 
 
 
 
 
5 
Chapter 2 
Background and literature review 
2.1) Graphene and its analogue: Structure and applications 
Graphene, the archetypal two-dimensional material, consist of a single-atom-thick 
layer of carbon atoms arranged in a hexagonal lattice structure22,23. Structurally, each 
carbon atom of graphene sheet is sp2 hybridized, with each carbon atom in the planer 
sheet is held together by s-bond whereas out of plane delocalized p-electron lead to the 
generation of weak van-der Waal forces between each layer of graphene in the bulk 
crystal structure, graphite24. Furthermore, electrons in graphene behave as Dirac 
fermions, enabling them to migrate in ambient conditions with little scattering25-27. The 
unique structural features of graphene leads to a wide range of extraordinary electronic 
properties, which includes room-temperature electron mobilities of ~10,000 cm-2s-1, 
charge carrier concentrations of 1013 cm-2, zero-bandgap 2D semiconductor behavior, 
unusual Hall effect for both electron and hole carriers and high thermal conductivity26,28-
31. Furthermore, graphene exhibits extraordinary mechanical strength, with breaking 
strength around 42 N m-1 and a Young’s modulus around 1.0 TPa32. The remarkable 
properties of graphene were further implemented for electronic applications, including 
high speed electronic and optical devices33-40, energy generation and storage41-47, hybrid 
materials48,49, chemical sensors50, and DNA sequencing51-53.  
Apart from the impressive mechanical and electrical properties of graphene, the 
high surface area and unique physiochemical properties of graphene have been further 
explored for wide range of biomedical applications and translational research, which 
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includes tissue engineering54, molecular imaging and gene therapy55. Despite of some 
successes in biological applications, the implementation of graphene for clinical 
applications is being hindered, due to its potential toxicity and biocompatibility towards 
mammalian cells56. The reason for graphene’s toxicity towards mammalian cells is still 
not well known, but presence of free electron on surfaces of graphene is considered a key 
factor, which imparts significant toxicity towards mammalian cells. To overcome this 
problem, researchers have modified the surface of graphene using chemical treatment to 
produce graphene oxide (GO) and reduced graphene oxide. The biocompatibility studies 
of GO on a,wide range of mammalians cell line such as L92957, HeLa58, human 
fibroblast59, human lung cancer cells A54960 and human hepatoma HepG261 showed no 
to little cytotoxicity.  
The biocompatibility and easy functionalization of GO inspired researchers to 
explore it further for biomedical applications. Furthermore, the high elasticity, flexibility 
and adaptability to flat or irregular shaped surfaces of graphene-based materials have 
been used for tissue engineering30,62. Studies have demonstrated graphene-based 
materials to promote growth, proliferation and adhesion of human mesenchymal stem 
cells and mouse induced pluripotent stem cells (iPSCs), with GO supporting better 
attachment and proliferation compared to graphene63-65. Also, the large surface area and 
versatile chemistry of graphene-based nanomaterial was further explored for 
development of probes for wide range of molecular imaging techniques such as magnetic 
resonance imaging (MRI), optical and positron emission tomography (PET). For 
example, Peng et al. designed a graphene based biocompatible intracellular imaging 
system by conjugating fluorescein on the surface of graphene using PEG linker66. In 
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another reports, Gollavelli et al. designed a graphene based multifunctional imaging 
systems using microwave assisted reduction of GO in the presence of ferrocene, which 
led to the formation of iron nanoparticles on the surface of graphene67.  
The ultrahigh surface area and large sp2 hybridized carbon area was further 
explored for drug delivery and gene delivery68. The large hydrophobic surface of 
graphene nanosheets was used for loading hydrophobic anticancer drugs using p-p 
stacking interactions. The high solubility of GO was further used to load water-insoluble 
aromatic cancer drugs such as SN38, which in turn overcomes the aqueous the 
insolubility problem of anticancer drugs69. Performance-wise these drugs loaded GO 
platform performs better than FDA approved SN38 prodrug, irinotecan69. In another 
report, to further increase the performance of GO based delivery vector, MCF-7 cell 
overexpressed receptor molecule, folic acid was covalently conjugated on the surface of 
graphene oxide and two anticancer drugs, DOX and CPT was loaded on the nanosheets, 
which in turn showed better performance than drug alone69. Also, GO based platform was 
further used for development of safe gene delivery vector for gene-based therapeutics. 
The attachment of plasmid DNA on the surface of graphene, prevents degradation of 
oligonucleotides from enzymatic cleavage. For graphene-based gene delivery, the most 
well-known techniques mainly involve attachment of cationic charged polymer, PEI on 
the surface of GO followed by electrostatic attachment of plasmid DNA70. Also, previous 
reports have shown the delivery of short interfering RNA and DOX using PEI grafted 
GO, which in turn shown higher anticancer efficiency compared to other systems71.  
Although graphene-based systems have shown promise for biomedical 
applications, their non-biodegradable nature coupled with long-term toxicity of 
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nanomaterials hinders its implementation for clinical applications. The drawback 
imposed by the graphene-based materials inspired researchers to hunt for other classes of 
two-dimensional materials, which led to the discovery of many other materials such as 
semiconducting two-dimensional transition metal dichalcogenides (TMDCs), boron 
nitride, borophene, silicene, germane and MXene.  
2.2) Transition metal dichalcogenides (TMDCs): Structure, Properties and 
Applications 
TMDCs are a class of layered materials where each transition metal (M) is 
sandwiched between two chalcogen atom (X) atomic layers to form a monolayer of 
atomic units MX2, with few exceptions such as 2:3 quintuple layers (M2X3) and 1:1 metal 
chalcogenides (MX)3,72. Based on the atomic arrangement, TMDCs can be further 
categorized into different geometric forms including trigonal prismatic (hexagonal, H), 
octahedral (tetragonal, T) and distorted phase (T’), Figure 1.2. In the single-layer 1H 
phase of TMDCs, each metal atom forms a tetrahedral geometry along +Z and -Z 
directions, and in multilayer structures, each tetrahedral layer is held together by weak 
van der Waals forces. In 1T phase, metal bonding with each chalcogen atom adopts a 
trigonal geometry with each phase are arranged in antiparallel orientations, to form an 
antiparallel trigonal prismatic geometry. In 1T’ phase, the crystal structure undergoes 
further distortion along z direction to form a distorted trigonal prismatic geometry73,74. 
Unlike graphene, TMDCs exhibit a finite bandgap. In bulk form, most TMDCs 
have an indirect band gap, whereas monolayer forms show a direct band gap, with few 
exceptions such as GaSe and ReS275,76. For example, TMDCs such as MoS2 (1.8 eV), 
MoSe2 (1.5 eV), (2H)-MoTe2 (1.1 eV), WS2 (2.1 eV) and WSe2 (1.7 eV) shows direct 
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band gap in monolayer form, whereas it shows indirect band gap in bulk form, Figure 1. 
2. Geometrically, the 2H phase is the most stable form for MX2 at room temperature, 
whereas MX2 phase transforms to the unstable 1T phase following chemical treatments or 
electron beam irradiations77. Electronically, 1T MoS2 phase is more conductive than the 
semiconducting 1H phase78. Contrary to MoS2, both 1T and 1T’ phase is stable for WSe2 
at room temperature, and lack of cohesive energy between each layer makes easy 
interconversion between two phases79. The d-block transition metal dichalcogenides such 
as titanium (Ti), chromium (Cr), nickel (Ni), vanadium (V), niobium (Nb) and tantalum 
(Ta) shows metallic behavior at room temperature3. 
 
Figure 1.1: Crystal structure and electronic properties of TMDCS (a) Crystal structure of 
TMDCs. Cleavable planes for three different crystal structure of TMDCs 1H, 1T and 1T’ 
is shown. (c) Band gap of 2D layered materials. The colors correspond to the wavelength 
of bandgap of layered materials. Figure adapted with permission from [80].  
 
The TMDC exhibit intrinsic semiconducting properties, with band gap increasing 
with decreasing thickness. The semiconducting property and high carrier electron 
mobility of TMDCs, have been further used for field-effect transistors. Furthermore, 
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TMDCs also exhibit exceptional mechanical properties. For example, Young’s modulus 
for few layers of suspended MoS2 nanosheet is ~0.33 ± 0.07 TPa80. Further mechanical 
studies of MoS2 have shown ~180 ± 60 N m-1 high in-plane stiffness and ~270 ± 100 Gpa 
Young’s modulus for single layer MoS280. The high crystallinity and defect free nature of 
atomically thin TMDCs led to better Young’s modulus, when compared to stainless steel 
and graphene oxide81. Furthermore, valence electrons of the metal atom undergo bonding 
with lone pair of electrons terminated from chalcogen plane, resulting in absence of 
dangling bonds on the basal plane of TMDCs which in turn makes it chemically inert, 
and making them a promising candidate for biomedical applications21. Also, TMDCs 
shows external environment dependent photoluminescence (PL), which is further 
exploited for designing of biosensors 16,82-85. Also, the electronic band structure of 
TMDCs exhibit stronger optical absorption in the near-infrared region (NIR), compared 
to graphene oxide and gold nanorods86. The NIR absorption of TMDCs was further 
explored for designing of photothermal agents for therapeutics and drug delivery in tumor 
tissues 83. For example, MoS2 at a concentration as low as few 100s ppm can increase the 
temperature to >80 °C on exposure to NIR for few minutes.83  
Depending on the application, there are two well-known approaches for synthesis 
of TMDCs, top-down and bottom-up. The bottom up approach refers to the synthesis of 
TMDCs starting from precursors. The most widely used bottom up approach is chemical 
vapor deposition (CVD), which refers to the techniques in which solid powder precursors 
are thermally evaporated and chemically made to react on a solid surface or substrate to 
form a desired TMDCs layer87,88. For example, MoS2 is synthesized by heating MoO3 and 
S powders in a glass tube to form vapors of Mo and S, which reacts on a substrate such as 
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SiO2 and sapphire to form MoS2 monolayer. The bottom up approach is highly efficient 
for formation of large area monolayer MoS2 surfaces, which makes it a perfect candidate 
for fabrication of large-scale diagnostic devices. The top-down approach refers to 
exfoliation of bulk crystal of TMDCs to its constituent layers using mechanical or 
chemical treatments.  
The most well-known top-down approach are, mechanical exfoliation and liquid 
exfoliation. The mechanical exfoliation of TMDCs involves the use of adhesive for 
breaking down interlayer force, followed by transferring of exfoliated flake on different 
surfaces or substrates6. The mechanical exfoliation of TMDCs generally yields high 
quality flakes, but less scope for thickness controllability, is the biggest drawback for 
these techniques. The high quality of flakes produced by mechanical exfoliation 
techniques makes it a perfect candidate for designing of chip-based sensors. The other 
technique, liquid phase exfoliation of bulk TMDCs crystal refers to ultrasound-assisted 
chemical exfoliation of TMDCs, and shear-force-assisted exfoliation of TMDCs in the 
presence of dispersing agents. The liquid phase exfoliation of TMDCs either involves the 
chemical treatment of TMDCs using intercalating reagents, n-BuLi, followed by 
ultrasonication to yield mono to few layers of TMDCs or in-situ ultrasonication of 
TMDCs in the presence of dispersing agents such as surfactants, biomolecules etc. to 
exfoliate and disperse TMDCs in solutions89. Although this technique leads to poorer 
quality nanosheets, the high concentrations and surface tunability with wide varieties of 
dispersing agents, make it one of most promising techniques for generation of 
nanomaterials for biomedical applications.  
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Figure 1.2: Techniques for synthesis and exfoliation of TMDCs (a) Chemical vapor 
deposition starting from precursor90 (b) Mechanical exfoliation of TMDCs from bulk 
crystal using tape method.91 (c) Liquid phase processing of TMDCs using sonication.92 
Figure adapted with permission from: (a) ref. [90] Copyright (2012), American Chemical 
Society. (b) ref [91] Copyright (2012), IOP Publishing (c) ref [92] Copyright (2015), 
Springer Nature. 
 
2.3) Biological applications of two-dimensional transition metal dichalcogenides 
For designing materials for use in biological systems, the first step involves 
careful engineering of the nanomaterial hybrid structure to enhance biological and 
nanomaterial interactions, without compromising the cellular viability towards human 
cells. The two well-known strategies in this regard are, functionalization and 
intercalation, Figure 1.4. Functionalization is a technique which involves covalent 
modification of basal plane or edges using well-known free radical and disulfide 
chemistry for attachment of biologically relevant functional moieties. For example, MoS2 
multi-functional drug carriers for cancer treatment were made using surface 
functionalization of MoS2 with lipoic acid conjugated PEG using thiol chemistry.93 In 
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intercalation strategies, TMDCs is dispersed either using chemical treatment or 
ultrasonication in the presence of biocompatible amphiphilic surfactant. In chemical 
exfoliation, TMDCs are treated using strong intercalating agents, n-BuLi, to intercalate 
small Li ions to weaken the interlayer forces, followed by ultrasonication in the presence 
of biologically functional moiety, which leads to exfoliation and functionalization of 
TMDCs94. The presence of toxic Li ion in chemical exfoliation hinders its biological 
applications. The other alternative strategy for exfoliation of TMDCs mainly involves in-
situ ultrasonication of TMDCs in the presence of biologically active amphiphilic 
molecules to generate biologically active molecules encapsulated nanosheets19. The in-
situ ultrasonication leads to generation of large chaotic forces in solution, which in turn 
lead to the breakdown of van der Waal forces between each layer, and amphiphilic 
molecules encapsulate nanosheets, which in turn provide stabilization to each nanosheets 
using electrostatic or steric repulsion. Despite its success in exfoliating the TMDCs, there 
are few reports for TMDCs exfoliation in the presence of biological active molecules 
such as peptides, proteins aptamers and DNA. According to Zadeh et al., the exfoliation 
of TMDCs in the presence of these molecules will require careful consideration of pH, 
temperature and energy consideration21.  
 
14 
 
Figure 1.3: Solution-phase processing of TMDCs using functionalization and 
intercalation for biological applications. A) Covalent functionalization of 1T phase of 
TMDCs nanosheets using a 2-iodomethane.95 (b) Disulfide functionalization of MoS2 
using thiol moieties. (c) Exfoliation of TMDCs using intercalation strategies: (i) general 
intercalation strategies, (ii) charged particle intercalation strategies, (iii) exfoliation and 
restacking processes. (d) HRTEM images showing exfoliated TiS2 ( e) Schematic 
showing the change in interlayer distance of TiS2, with change in carbon length of 
amine.96. Figure adapted with permission from [21]. Copyright © 2015 WILEY-VCH 
Verlag GmBH & Co. KgaA, Weinheim. 
 
Unlike graphene, the absence of dangling bonds on the basal plane of TMDCs has 
inspired researchers to explore the biological applications of TMDCs. Furthermore, high 
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surface area of TMDCs makes them promising candidates for designing systems for 
biological applications. Toxicity studies of TMDCs have shown them to be less toxic 
compared to graphene analogues.97,98Also, variations in the toxicity of TMDCs have also 
been observed for different TMDCs analogues. For example, MoS2 and MoSe2 did not 
impart any toxicity to lung cancer cells, whereas WSe2 induced significant toxicity, but 
lower than graphene and graphene oxide97. Other studies have shown increased toxicity 
of TMDCs, with decreasing MoS2 thickness, which can be attributed to the fact that 
defects and edges play a key role in toxicity of TMDCs17. Furthermore, in-vivo studies on 
PEG-functionalized MoS2, have shown no evidence of toxicity towards mice7. Also, the 
same results were observed for the PEG-functionalized metallic TMDC TiS2, with no 
significant toxicity was observed after 2 months of treatment.99  
The biocompatibility of TMDCs and high hydrophobic surfaces has led to their 
use as drug-delivering nano-carriers. The loading of hydrophobic drugs on the 2D surface 
of TMDCs increases the solubility and life span of drugs with the highest reported 
loading around 240%, higher than graphene oxide7,100. Furthermore, 2D TMDCs such as 
MoS2 also shown higher near infrared (NIR) absorbance compared to carbon-based 
material graphene. For example, NIR radiation of MoS2 suspension can change the 
temperature of the medium to >80 °C, which were applied for cancer treatments86. Also, 
the high surface area coupled with the photothermal properties of TMDCs is being used 
for developments of drug-delivery carrier for multimodal cancer treatment. For example, 
Yin et al. designed a multimodal synergistic delivery vector containing folic acid 
functionalized PEG on MoS2 surface and DOX on MoS2 surface, which was further used 
for destroying and delaying tumor growth93. Similar studies with other TMDCs such as 
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TiS2 and WS2, also showed biocompatibility and drug delivery carrier properties99,101.  
The ability of TMDCs to attenuate X-rays has been used for designing contrast agents for 
X-ray computed tomographic (CT) imaging7,10,101. Also, 2D MoS2 surfaces have been 
used for decorating with magnetic resonance imaging (MRI) contrast agents such as iron 
oxide and Cu64, and further used for photoacoustic imaging8. The biocompatibility, 
mechanical strength and material stiffness of these materials was further explored for 
designing of 2D TMDCs based matrix for tissue engineering102,103.  
Lastly, the high surface-to-volume ratio, wide range of functionalization strategy 
and intercalation property of TMDCs was used for designing biosensors. For example, 
Wu et al. designed MoS2 based redox sensor for detection of glucoses and dopamine104. 
The photoluminescence (PL) is another property which have been explored for designing 
of different sensor; the PL of 2D TMDCs can be changes based on intercalation with 
small molecule, which in turn can be used for detections of small molecules. For 
example, quenching of PL on intercalation with small molecules with TMDCs have been 
utilized for designing of blood glucose sensor.11,102  
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Figure 1.4: Cell imaging, photothermal effect and drug delivery applications of TMDCs 
(a) Fluorescence imaging of lung cancer cells using MoS2 nanosheets 85(b) Photothermal 
profile of MoS2 nanosheets with respect to concentrations. (c) Drug delivery pathway of 
2D TMDCs using clathrin-mediated endocytosis10. Figure adapted with permission from 
[21]. Copyright © 2015 WILEY-VCH Verlag GmBH & Co. KgaA, Weinheim. 
 
2.4) Antibacterial applications of two-dimensional materials 
The interesting features of nanomaterials such as high surface area and 
physiochemical properties have been widely explored for designing of wide range of 
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material-based antibiotics. The antibacterial action of these nanomaterial holds advantage 
over traditional antibiotics. Firstly, most of antibacterial actions of these material-based 
antibiotics is based on physical interactions and chemical reactions, which in turn restrict 
bacteria from developing resistance to nanomaterial-based antibiotics. Secondly, high 
surface area of nanomaterials allows loading of antibiotics, which has been used 
synergistically with nanomaterials for eradicating multidrug resistant bacteria. Thirdly, 
optical properties of nanomaterials are being further explored for designing of 
photothermal and photocatalytic based antibacterial systems. 
2.5) Antibacterial activity of graphene-based material and its analogue 
The interesting physiochemical properties of graphene-based materials (GM) was 
explored for designing of wide range of antimicrobial systems. Based on previous study, 
antibacterial mechanisms of GMs occur through two well-known mechanisms, physical 
interactions and oxidative stress.105-108  
The physical interactions refer to interactions of bacteria with the sharp edges of 
nanomaterials, which in turn led to breakdown of cell membrane and finally cell death. 
This antibacterial action of nanomaterials has been referred to as the ‘nano-knife’ effect. 
Hu et al. explored these features and demonstrated antibacterial activity of graphene 
oxide (GO) and reduced graphene oxide (rGO) against gram-negative E. coli, with 
graphene oxide having better antibacterial performance compared to rGO109. In another 
report, Akhavan and Ghaderi et al., compared the antibacterial activity of GO and rGO 
nanowalls, and established the fact the rGO showed stronger antibacterial activity 
compared to GO in solid phase.110  
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Apart from nano-knife effect of GMs, the basal edge of GMs also plays a key role 
towards antibacterial actions. For example, GMs encapsulate bacteria and cut off 
nutrients supply from the external environment, which in turn lead to cell death due to 
nutrient deprivations111,112. In another report by Liu and co-workers, they studied effect of 
lateral dimensions of GO towards antibacterial performance, with larger GO sheets 
showed higher activity compared to smaller ones113. Based on these studies, they 
postulated that larger graphene sheets are a better encapsulating agent compared to 
smaller ones, which in turn provide better shielding to bacteria from the external nutrient 
environment and contribute to different antibacterial activity. Also, the hydrophobic 
surface of GMs interacts with lipids of bacteria, which in turn causes membrane 
disruption and finally cell death.114,115 Furthermore, Tu and co-worker carried out an 
experimental and molecular simulations of the antibacterial action of GMs and revealed 
two mechanisms, one involving insertion and cutting, and other one involves destructive 
lipid extraction of bacterial cell membranes with the assistance of TMDCs hydrophobic 
surface. 115 
The other well-known antibacterial mechanism of GM based material involves 
generation and induction of oxidative stress. The oxidative stress generated by GMs is 
classified into two categories, reactive oxygen species (ROS) dependent and ROS 
independent. The ROS-dependent antibacterial mechanism refers to the generation and 
accumulation of ROS, which includes, singlet oxygen, superoxide oxygen, hydrogen 
peroxide and hydroxyl radical. The ROS independent refers to the interactions of 
nanomaterials with bacterial surfaces, followed by chemical reaction, which in turn led to 
induction of oxidative stress within the cell. The oxidative stress generated by GM based 
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material leads to lipid peroxidation and dysfunction of bacterial cellular machinery, 
followed by cell death.116 In this regard, Krishnamoorthy et al. incubated GO with free 
radical trapper, 5,5-dimethyl-1-pyrroline-N-oxide and used EPR to detect the free radical 
ion in the medium.117 Their study revealed hydroxyl radical as the key radical towards 
ROS dependent oxidative stress. Also, some studies showed GO dispersion generates 
higher ROS compared to rGO, which can be further co-related with the fact that GO have 
stronger antibacterial activity compared to rGO118,119. Contrary to these studies, others 
have shown that ROS-independent oxidative stress is a key mechanism towards 
antibacterial action of GM based material. For example, Liu et al. compared the 
antibacterial activity of four different GMs (GO, rGO, Graphene and Graphite oxide) and 
showed the antibacterial performance and found it follows the order, GO > rGO > 
Graphite > Graphite oxide.120 Further mechanistic study revealed membrane damage and 
GSH as a key in antibacterial action, with no observed superoxide ion generation. In 
another study, Panda et al. coated graphene on four different conducting metal surfaces, 
Zn, Sn, Ni and steel, and glass as an insulating surface. The antibacterial activity study on 
these surfaces revealed GO-Zn being the most effective one, followed by GO-Ni, GO-Sn, 
GO-steel, with no antibacterial activity observed for GO-glass.121 From these studies, it 
can be concluded that antibacterial action is directly dependent on conductivity of 
surfaces with highest antibacterial action observed for highest conductive surfaces. 
Despite of all these studies, the exact antibacterial mechanism for graphene-based 
material is still unknown and needs further investigation. 
Furthermore, photothermal and photocatalytic property of GMs, was further 
explored for designing of antibacterial materials. The photothermal method refers to the 
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generation of local heat on incident of light, whereas photocatalytic property refers to 
production of free radical such as superoxide and peroxide ion, which in turn lead to 
generation of oxidative stress in bacterial cell. Interestingly, one atomic thick layer 
graphene is nearly transparent to NIR absorption with no photothermal activity, whereas 
rGO exhibits extraordinary photothermal activity. Khan et al. demonstrated GO based 
photothermal therapy for antibacterial activity, antifungal activity and accelerated wound- 
healing122. In another report, Wang et al. specifically modified the surface of rGO with 
anti- S. aureus antibody and specifically made it to target and eradicate S. aureus using 
photothermal therapy123. In another report, Qian et al. designed a pH-dependent 
photothermal antibacterial system by specifically conjugating glycol chitosan with the 
carboxy group of graphene.124 The pH dependent systems are negatively charged in 
healthy tissues, whereas it undergoes transition to positive charge in acidic environment 
of wounds and becomes more active in infected areas.  
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Figure 1.5: Antibacterial actions of graphene-based materials.125 Figure adapted with 
permission from: ref. [125] Copyright (2016), American Chemical Society. 
 
2.6) Antibacterial activity of non-graphene two-dimensional materials 
The antibacterial activity of GMs inspired researcher to study the antibacterial 
activity of other classes of materials, in particular TMDCs. Previous studies on 
antibacterial action of TMDCs, showed oxidative stress, membrane rupture and release of 
MoO42- as two key antibacterial mechanism.126,127 Previous studies on antibacterial action 
of MoS2, have shown chemically exfoliated ce-MoS2 have stronger antibacterial activity 
compared to raw MoS2.126 These antibacterial actions can be attributed to the fact that ce-
MoS2 has stronger interactions with bacteria compared to raw MoS2, which in turn 
induces higher oxidative stress and membrane rupture to bacterial cell. In another study, 
Wu et al. studied the effect of MoS2 nanosheets on metabolic pathways of E. coli and 
revealed that there is no change of metabolites expression in E. coli at low concentrations 
of MoS2 nanosheets, whereas it suppressed the expression of metabolites at high 
concentrations of MoS2 nanosheets127. In another study, Tang et al. vertically aligned 
MoS2 was generated on Ti substrates and the antibacterial activity tested on both gram-
negative E. coli and gram-positive S. aureus.128 Based on their studies, MoS2-coated Ti 
substrates inhibited both strains of bacteria, but two different antibacterial mechanisms 
were reported for these strains. The S. aureus elimination occured through both ROS and 
MoO42- ion release, whereas E. coli elimination occured only through ROS, with no 
effect from MoO42- ion.  
To further increase the antibacterial efficiency of TMDCs, researchers have 
modified the antibacterial systems using functionalization, loading and catalytic 
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properties. In one report, Kim et al. modified MoS2 using GO and studied the 
antibacterial activity against bacteria using label-free holotomographic microscopic 
techniques129. Their study revealed that an ROS-independent pathway is responsible for 
antibacterial activity. In another study, Pal et al. anchored titanium nanoparticles on the 
surface of MoS2 and showed membrane damage and oxidative stress as a key mechanism 
towards antibacterial action.130 Researchers explored the high surface area and 
functionalization chemistry of MoS2 and anchored different cationic analogues on the 
surface of MoS2. In another report, Pandit et al. functionalized MoS2 with cationic 
ammonium derivatives of different length and studied the antibacterial activity against 
superbugs.131 According to their study, the cationic analogues successfully eradicated 
both planktonic cells and biofilms, using oxidative stress and membrane depolarization. 
The high surface area of MoS2 was further explored for designing of synergistic systems 
containing antibiotics and bactericidal silver nanoparticles. Using thiol functionalization 
chemistry, Cao et al. attached silver ions on cysteine-modified MoS2 nanosheets and 
further coated them with positively charged cationic polyelectrolyte 
polydiallyldimethylammonium chloride (PDDA).132 The system successfully eradicated 
planktonic from both in-vitro and in-vivo systems. Also, these systems showed better 
efficiency compared to silver ion generated from equivalent concentrations of silver 
nanoparticles. In another report, Zhang et al. functionalized MoS2 using chitosan and 
loaded the surface with the antibiotic tetracycline hydrochloride, which synergistically 
eliminated bacteria and biofilms.133  
The photothermal and photocatalytic properties of MoS2 were also explored for 
designing antibacterial systems. In one report, Fan et al. studied the antibacterial activity 
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of two classes of MoS2, chemically exfoliated MoS2 (ce-MoS2) and annealed chemically 
exfoliated MoS2 (Ae-MoS2) in the presence of the sacrificial electron donor 
ethylenediaminetetraacetic acid (EDTA).5 The ce-MoS2 showed higher photocatalytic 
antibacterial activity compared to Ae-MoS2, which is attributed to the fact that ce- MoS2 
has a higher concentration of 1T-phase compared to 1H phase. The 1T-phase has a 
favorable band gap for generation of ROS under visible-light illumination compared to 
1H-phase. In another report, Liu et al. designed few-layer vertically aligned MoS2 (FLV- 
MoS2), which was further implemented for water disinfection under incident visible light. 
The FLV-MoS2 has a higher band gap compared to bulk MoS2, which in turn favors the 
generation of more ROS in water and higher disinfection efficiency. Furthermore, Cu-
deposited FLV-MoS2 showed accelerated disinfection efficiency compared to pristine 
FLV-MoS2. The disinfection mechanism of FLV-MoS2 is due to photoinduced 
production of ROS, with H2O2 as the key ROS species involve in elimination of 
bacteria.134 
TMDCs also show peroxidase-like catalytic activity, which have been further 
used for designing peroxidase-based antibacterial systems. Yin et al. designed a PEG 
functionalized MoS2 based nanoflower and used it in synergy with low concentrations of 
H2O2 to generate hydroxyl radical. The hydroxyl radical induced oxidative stress in 
bacterial cells, which in turn led to elimination of bacteria.135 In another report, Huang et 
al. exfoliated TMDCs in the presence of carboxyl modified silk fibroin (CMSF), studied 
the peroxidase activity of TMDCs and used it for in-vivo wound dressing. According to 
their study, MoSe2-CMSF showed the best peroxidase performance among all other 
TMDCs, catalyzed H2O2 to generate hydroxyl radical, which in turn eliminated bacteria. 
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The MoSe2-CMSF was used with disinfectant H2O2 in wound dressing, which accelerated 
the healing rate compared to H2O2.136 Furthermore, there is some reports using WS2 for 
antibacterial activity. For example, Liu et al. coated WS2 with SDS and used it for 
antibacterial activity against E. coli using membrane damage and oxidative stress.137 
Bang et al. coated WS2 and WSe2 with long single-stranded DNA and demonstrated 
antibacterial activity of DNA-coated WS2 and WSe2 against E. coli. According to their 
study, WSe2-ssDNA demonstrated stronger antibacterial activity compared to WS2-
ssDNA, which has been attributed to the fact that p-type semiconducting behavior of 
WSe2 promotes stronger antibacterial activity compared to WS2.20 
 
Figure 1.6: Antibacterial action of TMDCs using photothermal, photocatalytic, 
membrane-induced damage and peroxidase catalysis. (a) 3D tomogram images of the 
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bacterial membrane after contacting GO-MoS2 surfaces. The image demonstrated 
disrupted bacterial membrane.129 (b) Covalently functionalized MoS2 with positively 
charged cationic polymer having varying carbon chain length. (c) Change in membrane 
polarization after interactions with covalently functionalized MoS2 with cationic charged 
polymer131. (d) Schematic images demonstrating the synergistic effect of antibiotic 
loaded MoS2 for disruption of biofilms. The chitosan charged MoS2 nanosheets disrupt 
biofilms extracellular matrix and deliver antibiotics inside biofilms to eliminate bacteria. 
Photothermal heating curve of chitosan functionalized MoS2 after irradiation with a 
laser.138 (f) Thermal mapping of corresponding chitosan modified MoS2 (figure e) after 
irradiation with laser. (g) Photocatalytic effect of vertically aligned MoS2 to generate 
reactive oxygen species after irradiation with visible light. Incident of visible light on 
vertically aligned MoS2 led to generation of reactive oxygen species which led to 
generation of oxidative stress in bacteria and finally cell death.134 (h) Schematic 
demonstrating peroxidase catalytic like activity of MoS2 nanoflower in the presence of 
H2O2 to generate reactive oxygen species for elimination of bacteria. Figures adapted 
with permission from: (a) ref [129]. Copyright (2017), American Chemical Society. (b, c) 
ref [131] Copyright (2016), American Chemical Society (d, e, f) ref [138] Copyright © 
2016 WILEY-VCH Verlag GmBH & Co. KgaA, Weinheim. (g) ref [134] Copyright 
(2016) Springer Nature (h) ref [135] Copyright (2016), American Chemical Society 
 
Researchers have also explored the antibacterial activity of another class of two-
dimensional materials called Mxenes. There are only few reports on the antibacterial 
activity of Mxene. The first report on antibacterial activity of Mxene was done by Rasool 
et al., who studied Ti3C2Tx. According to their study, Ti3C2Tx eliminates both gram-
positive B. subtillis and gram-negative E. coli using sharp edge induced membrane 
rupture and oxidative stress.139 Extending these studies, Rasool et al. coated hydrophilic 
Ti3C2Tx on polyvinylidene fluoride membranes and demonstrated the anti-biofouling 
property of the membrane140. In another study, Pandey et al. demonstrated rapid water 
purification using Ti3C2Tx coated membrane.141 Despite of these reports on antibacterial 
activity of Mxene, there is still lot unknown about the probable antibacterial mechanism 
of Mxene.  
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Chapter 3 
Elimination of Multidrug Resistant Bacteria by Transition Metal Dichalcogenides 
Encapsulated by Synthetic Single-Stranded DNA 
3.1) Introduction 
 Antibiotic drug resistance is recognized as one of the most pressing threats to 
global health. Spurred by the misuse and overuse of commonly prescribed antibiotics, 
drug-resistant bacteria are becoming increasingly common and infections that were once 
easily treated can now force patients into extended hospital stays. In the United States 
alone, infections by drug-resistant bacteria have been estimated to cause 2 million cases 
of serious illness and 23,000 deaths each year, leading to billions of dollars in economic 
and societal costs142. Despite this alarming threat, the number of antibiotics under 
development remains low, raising the possibility of rampant drug resistance reversing 
many of the advances of modern medicine. This global health challenge thus demands 
new approaches to combatting and eradicating bacterial infections. 
 Two-dimensional (2D) materials have emerged as promising antibacterial 
materials owing to their high surface areas and atomically thin edges, which can promote 
strong interactions with bacterial cell walls, and in some cases the ability to generate 
redox species to trigger cell death. Furthermore, the multifaceted antibacterial killing 
action of 2D materials compared to traditional antibiotics, makes the development of 
resistance less likely. Out of these materials, graphene and its close relative graphene 
oxide (GO) have been most extensively studied and have provided varying levels of 
antibacterial activity depending on the preparation and treatment method.139 In one 
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particularly effective preparation, graphene oxide paper showed 98.5% Escherichia coli 
inhibition at 85 µg ml-1, whereas 100% elimination was observed for Pseudomonas 
aeruginosa at 100 µg ml-1.143 Electrochemically produced graphene quantum dots 
induced oxidative stress in bacteria and eliminated 80% of E. coli and 92% of 
Staphylococcus aureus.144 Furthermore, Tu et al. studied the antibacterial action of GO 
using molecular dynamic simulations and experimental studies. They showed that 
insertion and cutting of the bacterial cell membrane using the sharp edges of GO, 
followed by destructive extraction of lipid molecules of bacterial membrane as key 
mechanism for elimination of bacteria.114 Transition metal dichalcogenides (TMDCs), 
which have been shown to have better biocompatibility than graphene and can be 
enzymatically degraded, have also been studied for antibacterial activity 145. Chemically 
exfoliated MoS2, for instance, successfully killed 93.4% of E. coli cells upon exposure at 
80 µg mL-1 146 while the same concentration of WSe2 coated by long strands of salmon-
derived DNA eliminated only 82.3% of the same bacteria147. Hydrothermally synthesized 
WS2 was shown to kill 98.67% and 99.98% of E. coli and Bacillus subtilis cells, 
respectively, but only at very high concentrations of 250 µg mL-1.  
Despite their clear antibacterial activity, these 2D TMDCs failed to match the 
activity of common antibiotics, which can eliminate >99.999% of cells at similar or lower 
concentrations. To obtain comparable levels of activity, 2D TMDCs have required more 
aggressive conditions and light-driven reactions. WS2 dispersed in the surfactant 
solutions completely eliminated cultures of E. coli and S. aureus, but it exhibited 
significant toxicity toward human cell lines.137 Liu et al. demonstrated a water 
disinfection system that employed vertically aligned MoS2 layers visible light to 
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eliminate >99.999% of E. coli and Enterococcus faecalis cells; however, this light-driven 
mechanism would be challenging to apply to wound bacterial infections148. In another 
report, Pandit et al. covalently conjugated hydrophobic variants of quaternary ammonium 
salts to chemically exfoliated and ultrasonicated MoS2 using disulfide chemistry and 
demonstrated elimination of planktonic gram-positive S. aureus, gram-negative P. 
aeruginosa and biofilms, using membrane polarization and oxidative stress.18,131 In 
another report, peroxidase-like catalytic activity of MoS2 nanoflowers was explored for 
generating hydroxyl radical from H2O2, which in turn led to generation of oxidative stress 
and cell death.135 Despite of these successes, the harsh treatment conditions, difficult 
synthetic routes, light-driven mechanism and toxicity towards mammalian cells of 
previously developed systems hinders their implementation in clinical applications.  
 Herein, we describe a novel preparation of 2D TMDCs, in particular of MoSe2, 
that provides remarkable antibacterial activity against multidrug resistant (MDR) strains 
bacteria. These antibacterial materials consist of 2D TMDCs coated by short sequences 
of single-stranded ssDNA. By using appropriate sequences of ssDNA, we successfully 
prepared stable dispersions of MoS2, MoSe2, WS2, and WSe2 in aqueous solution and 
confirmed their two-dimensional character using TEM and AFM. We find that MoSe2 
nanosheets encapsulated by the T20 DNA sequence do not exhibit toxicity against human 
cells yet are capable of complete elimination of ‘ESKAPE’ strains at concentrations as 
low as 75 µg mL-1 and provide substantially higher antibacterial activity than widely 
studied graphene oxide and other preparations of 2D TDMCs. Further mechanistic 
analysis of MoSe2/T20 showed that the sharp edges of the nanomaterials leads to insertion 
into the bacterial cell membrane causing membrane damage, followed by change in 
 
30 
membrane potential and generation of oxidative stress, which in turn triggers 
programmed cell death. 
3.2) Results and Discussion  
3.2.1) Exfoliation and encapsulation of 2D TMDCs using short ssDNAs 
 Inspired by previous work exploiting single-stranded DNAs for wrapping single-
walled carbon nanotubes149-156, we attempted to use short synthetic ssDNA sequences for 
exfoliation and stabilization of four TMDC compounds: MoS2, MoSe2, WS2, and WSe2. 
Based on the amphiphilic structure of ssDNA, we anticipated that the hydrophobic DNA 
bases would undergo strong π-stacking interactions with the hydrophobic surfaces of the 
TMDCs, enabling the hydrophilic sugar-phosphate ssDNA backbone to interface with 
surrounding water molecules. The negatively charged phosphate groups in the backbone 
would also provide strong electrostatic repulsion to suspend each flake in solution and 
prevent nanosheet restacking (Figure 1a). Given the sequence dependence of ssDNA 
dispersions of carbon nanotubes157, we investigated the ability of seven 20-nucleotide (nt) 
ssDNAs containing different sequences of the four canonical DNA bases adenine (A), 
cytosine (C), guanine (G), and thymine (T)  to disperse the TMDCs. These sequences 
contained 20-mer repeats of the bases (A20, C20, and T20); or they consisted of repeated 
pairs of non-complementary bases ((GT)10, (CA)10). Since long guanine repeats are 
challenging to synthesize, we instead studied the guanine-rich ssDNAs (GGGGA)4 and 
(GGGGT)4. 
Bulk TMDC powders were probe ultrasonicated in aqueous solutions containing 
0.2 mg mL-1 of synthetic ssDNA. The ultrasonicated solutions were then centrifuged and 
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the resulting supernatants harvested. Figure 1b provides a photograph of the strongly 
colored and stable 2D TMDCs dispersions prepared using the common sequence T20, 
which was an effective sequence for dispersing all four of the TMDCs. Optical 
absorbance spectroscopy of the dispersions confirmed successful exfoliation of the 
TMDCs revealing the characteristic excitonic transition peaks for the four compounds 
(Figure 1c). 
The concentrations of the TMDCs dispersed in the synthetic ssDNAs were 
determined using inductively coupled plasma mass spectrometry (ICP-MS). MoSe2 and 
WSe2 yielded the highest concentration dispersions with loadings above 250 µg mL-1 
obtained for optimal ssDNA sequences. The sulfur-containing MoS2 and WS2 displayed 
lower loadings, in general, with typical concentrations of 50 µg mL-1. We further 
evaluated the stability of DNA wrapped TMDCs using zeta potential, with MoSe2 and 
WSe2 being the most stable with zeta potentials of -42.13 and -40.13 mV, respectively, 
whereas MoS2 and WS2 were the least stable with zeta potentials of -21.13 and -20.07, 
respectively (Figure A 3). We observed significant variations in the concentration of 
dispersed TMDCs depending on the sequence of ssDNA used and the composition of the 
TMDC. In general, the highest concentration dispersions were obtained for the T20 
sequence whereas (CA)10 was the weakest out of all sequences studied. Our study also 
revealed thymine and guanine showed better affinity towards all TMDCs compared to 
cytosine and adenosine. After determining that T20 and MoSe2 provided the highest 
concentrations overall, we further evaluated the DNA coverage of MoSe2/T20 using 
Thermogravimetric analysis. These measurements indicated ~8% DNA coverage on the 
surface of the TMDCs. (Figure A2). The repeating dinucleotide sequence GT was also 
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tested with ssDNAs of different lengths, in particular 10-nt, 20-nt, and 40-nt lengths. We 
found that (GT)10 provided the highest concentrations out of the three, and that MoS2 
ssDNA with (GT)5 was unstable and aggregated within a few hours. 
 
Figure 2.1: Exfoliation and encapsulation of 2D TMDCs using short ssDNAs. (a) 
Schematic illustrating exfoliation and coating of TMDCs in ssDNA (b) Picture of sample 
vials demonstrating stable dispersion of TMDCs in T20 DNA sequence. (c) UV-Vis-NIR 
spectroscopy of ssDNA-dispersed TMDCs demonstrating the 2H phase of the TMDCs 
after exfoliation. (d) Sequence dependence of ssDNAs used for dispersing TMDCs 
determined using ICP-MS. 
 The successful exfoliation of 2D TMDCs using low molecular weight ssDNA was 
further characterized using low and high-resolution transmission electron microscopy  
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(TEM and HRTEM) and atomic force microscopy (AFM) as shown in Figure 2. TEM 
imaging of the exfoliated TMDCs revealed their geometries as 2D nanosheets. The 
average lateral size of nanoflakes decreased in order from MoS2, WS2, MoSe2, and WSe2 
(Figure 2a-d). MoS2 yielded nanoflakes with lateral dimensions of approximately 80-100 
nm, WS2 and MoSe2 from 60-70 nm, and WSe2 less than 50 nm. AFM images of MoS2 
confirmed the presence of flakes with extended lateral dimensions with thicknesses of 
around 10 nm (Figure 2e). The WS2 dispersion showed the second largest flakes with 
thicknesses less than 8 nm (Figure 2f), whereas MoSe2 and WSe2 exhibited the smallest 
flakes with thicknesses around 8 nm (Figure 2g) and 4 nm (Figure 2h). The measured 
thicknesses of TMDC flakes also include a uniform layer of ssDNA, which covers both 
sides of the TMDC flakes. The AFM and TEM data obtained correlate well with each 
other and both showed successful ssDNA-based exfoliation of TMDCs to produce few-
layer TMDCs. We further studied the crystal structure of DNA dispersed TMDCs using 
HRTEM (Figure 2 a, b, c, d). These images showed that the TMDCs retains the expected 
hexagonal lattice structure of the pristine 2H phase of TMDCs following encapsulation 
by ssDNAs. 
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Figure 2.2: Microscopic characterization of ssDNA-dispersed TMDCs (a, d, g, i) 
Transmission electron microscopy (TEM) of ssDNA-dispersed TMDCs. TEM images 
demonstrate the nanosheet morphology of exfoliated TMDCs. (b, e, h, k) High resolution 
transmission electron microscopy (HRTEM) of ssDNA-dispersed TMDCs demonstrated 
hexagonal crystal structure of nanosheets. (c, f, i, l) Atomic force microscopy (AFM) 
demonstrates thin nanosheets with thickness around 6 to 8 nm, which further proves 
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successful DNA based exfoliation of TMDCs. AFM was done by Duo Li. HRTEM 
images were taken by Matt Gilliam. 
3.2.2) Molecular dynamics simulations for representative ssDNA/2D-TMDC surface 
structures 
We collaborated with the Ulissi group at Carnegie Mellon to perform molecular 
dynamics simulations to better understand the observed sequence-dependent 
encapsulation effects and the coating formed by ssDNA around the 2D TMDC’s. 
Literature efforts had previously characterized the interaction energy and representative 
ssDNA conformations for single base pairs and short uniform sequences (G6, T6, A6, C6). 
For three of the sequences, (GT)10, (AC)10, and T20, and two 50 nm X 50 nm 2d TMDC 
sheets (MoS2 and MoSe2), we performed long timescale molecular dynamics relaxations 
of approximately 100ns per system using the NAMD software and VMD for 
visualization. The force field, parameters, and explicit water model were chosen for 
consistency with previous studies, with final structures shown in Figure 3. We found that 
the T20 sequences consistently had the strongest interaction energy with the 2D TMDCs 
and formed extended flat sequences along the surface such that every base pair was in 
contact with the 2D TMDCs. The (GT)10 sequences for both 2D TMDCs had similar 
structures for base pairs adsorbed to the surface driven by T base adsorption but had 
extended sequences off of the surface that could possible leader to thicker adsorption 
layers than the tightly bound T20 strands. The (AC)10 strands tended to form stacked 
structures with A bases adsorbed to the surface, and C bases adsorbed on top of those. 
These results qualitatively explain the observed trends in ssDNA dispersion efficiency 
shown in Figure 1. We also calculated the interaction energy solely between the ssDNA 
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and the 2D TMDC sheets (i.e. ignoring water energetics), with T20 have uniformly the 
strongest interactions, as expected since every base pair was adsorbed. For all three base 
pairs the interaction energy was less strong for the MoSe2 surfaces than for the MoS2 
surfaces, suggesting that interaction energy was inversely correlated with experimental 
solubility. Thermodynamic free energy adsorption energy calculations could describe 
these interactions more accurately, but the timescales associated with adsorption and 
desorption of such large molecules was prohibitively expensive. 
 
Figure 2.3: Molecular dynamics simulation demonstrating interactions of three different 
DNA sequences T20, (GT)10 and (CA)10. Simulations were done by Dr. Zack Ulissi.  
3.2.3) Antibacterial activity of MoSe2/ssDNA 
 Since MoSe2 dispersions provided the highest concentrations of 2D TMDCs 
overall and were coated with a biocompatible polymer, we chose to study the effect of 
MoSe2/T20 dispersions on human and bacterial cells. To assess their toxicity, MoSe2/T20 
nanosheets were first added to cultures of the model HeLa human epithelial carcinoma  
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cell line. Concentrations of MoSe2/T20 ranging from 25 µg mL-1 to 250 µg mL-1 were 
applied to cultures for 24 hours and cell viability was determined using the colorimetric 
MTT assay. No significant toxicity was observed for MoSe2/T20, with 100% cell viability 
at all concentrations tested as shown in the Figure A 1. 
Having confirmed the biocompatibility of MoSe2/T20 nanosheets, we next 
evaluated their effect on two representative strains of gram-negative and gram-positive 
bacteria, E. coli MG1655 and Staphylococcus aureus subsp. Aureus (ATCC 29213), 
respectively. For determination of antibacterial activity, logarithmic-phase bacteria at a 
concentration of 107 cell-forming units per mL (CFU mL-1) were treated with MoSe2/T20 
dispersions at different concentrations for 4 hours. Microdilutions of the treated bacteria 
were then applied to agar and incubated overnight for colony counting the next day. The 
MoSe2/T20 dispersions displayed exceptional antibacterial activity against both species of 
bacteria. We observed 100% elimination of E. coli at a concentration of 150 µg mL-1 
MoSe2/T20 (Figure 4a). For S. aureus, MoSe2/T20 displayed more potent activity, 
completely eliminating the gram-positive strain at a concentration of only 75 µg mL-1 
(Figure 4b). 
Recently, the antibacterial activity of carbon-based 2D materials has drawn wide 
attention.110,158-161 In a recent report, Liu et al. carried out a comparative study of 
antibacterial activities of four different graphene-based materials (graphite, graphite 
oxide, graphene oxide and reduced graphene oxide), with graphene oxide (GO) showing 
the strongest bactericidal effect.160 Thus, we compared the antibacterial activity GO, 
double stranded DNA encapsulated Graphene (Graphene/dsDNA) with respect to 
MoSe2/T20 on wild-type gram-negative E. coli MG1655 and gram-positive S. aureus 
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strain under the same experimental conditions. GO and MoSe2/T20 were incubated with 
E. coli MG1655 and S. aureus for 4 hours, plated on agar, and cell viability was 
determined by colony counting. For S. aureus, 75 µg ml-1 of MoSe2/T20 showed 3-log 
higher killing compared to GO, whereas 6-log higher activity was observed compared to 
graphene/dsDNA. For E. coli, at 150 µg ml-1 of MoSe2/T20 showed 3-log higher 
antibacterial killing compared to graphene oxide and 3-log higher killing compared to 
graphene/dsDNA (Figure 2.4 a and b). Furthermore, MoSe2/T20 exhibits higher 
antibacterial killing at all the tested concentrations compared to GO and 
graphene/dsDNA. The higher antibacterial efficiency of MoSe2/T20 compared to GO and 
Graphene/dsDNA, can be attributed to the bulkiness of systems as a key factor towards 
difference in antibacterial activity. The higher size of dsDNA on graphene inhibits its 
interactions with negatively charged bacteria. In case of GO, the presence of negatively 
charged oxygen group and higher size nanosheets compared to MoSe2/T20, led to lower 
antibacterial activity of GO compared to MoSe2/T20. 
To determine if the short synthetic DNA coating contributed to the enhanced 
antibacterial activity of the MoSe2 nanosheets, we then carried out comparative studies 
with MoSe2 encapsulated by three biocompatible polymers: T20 ssDNA, long genomic 
DNA purified from salmon testes, and the block copolymer Pluronic F77. A recent report 
by Bang et al. demonstrated that WSe2 suspended using long genomic DNA had two-fold 
higher antibacterial activity than GO147. Pluronic F77 has been widely used for preparing 
biocompatible dispersions of 2D nanosheets162 and consists of a hydrophobic 
polypropylene oxide block flanked by two hydrophilic polyethylene oxide regions. In our 
experiments, we found that MoSe2/T20 showed significantly stronger bactericidal 
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properties compared to MoSe2/long genomic DNA and MoSe2/F77 for nearly all the 
concentrations tested and provided stronger enhancements as the concentration increased 
(Figure 2.4 c and d). At 150 µg mL-1 concentrations, MoSe2/T20 completely eradicated E. 
coli, which corresponded to the elimination of all 107 cells treated, while the activity of 
MoSe2/long genomic DNA and MoSe2/F77 was 2.2 and 3.2 logs weaker, respectively. 
Also, MoSe2/T20 showed 4 and 3 logs higher killing towards S. aureus when compared 
with MoSe2/long genomic DNA and MoSe2/F77.The variation in antibacterial activity 
with changes in polymer coating on MoSe2 can be attributed to the fact that, with 
increases in the bulkiness of polymer coating on the nanomaterial surface, there is 
reduction in the interactions of nanosheet edges with the bacterial cell membrane. The 
Pluronic F77 employs bulky polyethylene oxide blocks to suspend the MoSe2 in the 
aqueous environment; however, these polymer blocks discourage strong interactions with 
the bacterial cell wall. For the long genomic DNA, the use of long DNA sequences 
prevents the formation of a conformal ssDNA coating around the MoSe2 and thereby 
increases the effective thickness of the nanosheets. In contrast, the short length of the T20 
sequence enables the ssDNA to effectively coat and spread out along the MoSe2 surface 
and yields an ultrathin material to promote piercing of the bacterial cell wall. 
Furthermore, simple thermodynamic arguments suggest that molecules with 
proportionally larger length and adsorption energies will, at the same base pair 
concentration in solution, result in higher surface packing densities than for shorter 
molecules with smaller adsorption energies since the free energy is an exponential 
function, and should thus yield thicker nanosheets for longer DNA lengths. 
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Figure 2.4: Antibacterial activity of ssDNA-dispersed TMDCs (a, b) Comparison of 
antibacterial activity of MoSe2/T20 with respect to carbon-based materials, graphene 
oxide and double stranded DNA dispersed graphene on two gram-positive S. aureus and 
gram-negative E. coli. (c, d) Comparison of antibacterial activity of MoSe2/T20 with 
respect to two different dispersing agents, double stranded DNA and Pluronic- F77. (e) 
Antibacterial activity of MoSe2/T20 on multidrug resistant gram-negative E. coli strains 
NDM 2340, NDM 2471 and KPC 2469. (f) Antibacterial activity of MoSe2/T20 against 
gram-positive ‘ESKAPE’ strains. (g) Antibacterial activity of MoSe2/T20 against gram-
negative ‘ESKAPE’ strains. 
3.2.4) Antibacterial Studies Against MDR Bacteria 
 The continuing emergence of nosocomial infections by bacteria with broad-
spectrum resistance to antibiotics in hospitals and clinics requires novel antibacterial 
strategies. We sought to determine if the MoSe2/T20 dispersions retained their exceptional 
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bactericidal activity against several multidrug resistant strains. We first evaluated three 
strains of multi-drug resistant (MDR) E. coli carrying resistance to carbapenems, a class 
of antibiotic agents often used to combat drug-resistant infections. E. coli NDM 2469 and 
E. coli NDM 2471 strains both carry the New Delhi metallo-β-lactamase (NDM), a 
recently identified carbapanemase, while E. coli KPC 2340 carries the Klebsiella 
pneumoniae carbapenemase (KPC). All three strains exhibited broad-spectrum resistance 
to multiple families of antibiotics. Antibiotic resistance tests conducted by ATCC on the 
NDM 2469 and NDM 2471 strains indicated that these strains were resistant to 33 and 32 
out of 35 antibiotics tested. Studies by ATCC on E. coli KPC 2340 indicated that it was 
resistant to 30 out of the 34 antibiotics evaluated. The three MDR E. coli strains were 
exposed to different concentrations of MoSe2/T20 over 4 hours and surviving cells 
counted after plating microdiluted samples. No viable E. coli bacteria were observed after 
treatment with 150 µg ml-1 of MoSe2/T20, and the killing efficiency increased with 
increasing concentration (Figure 2.4e). At lower concentrations of MoSe2/T20, higher 
killing efficiency was observed for NDM E. coli strains compared to KPC E. coli strains, 
as shown in Figure 4. At 100 µg ml-1, MoSe2/T20 showed 99.98% and 99.8% cell killing 
for NDM strains, whereas 99.5% cell killing was observed for KPC strains.  
      After successful eradication of MDR E. coli, we further evaluated antibacterial 
efficiency of MoSe2/T20 on nosocomial-based MDR and clinical isolate ‘ESKAPE’ 
strains. We first evaluated efficiency of MoSe2/T20 on two well-known gram-positive 
clinical strains, Methicillin- resistant Staphylococcus aureus (MRSA) and vancomycin 
resistant Enterococcus faecium (VRE). MRSA, which is responsible for 25 to 50% of 
nosocomial infections expresses the mecA gene, which provides resistance to a broad 
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spectrum of ß-lactam antibiotics, whereas VRE, which causes nosocomial urinary tract 
infections, is resistant to all ß-lactam antibiotics and last resort antibiotics, vancomycin. 
After 4 hours of treatment, 75 µg ml-1 MoSe2/T20 successfully eliminated VRE and 
MRSA by 7 logs (Figure 2.4 f and g). We further extended our study, and checked the 
efficiency on gram-negative ESKAPE’ strains, which includes Klebsiella pneumoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter. Antibiotic 
resistance conducted by ATCC on Pseudomonas aeruginosa and Acinetobacter baumanii 
strains, demonstrated resistance to 15 and 31 different classes of antibiotics whereas 
Enterobacter and Klebsiella pneumoniae demonstrated resistance to all tested 36 
different classes of antibiotics. After 4 hours of treatment, 75 µg ml-1 of MoSe2/T20 
successfully eradicated all the four gram-negative MDR strains. We successfully 
eliminated all the ‘ESKAPE’ bacterial strains at concentration as low as 75 µg ml-1. The 
species-independent antibacterial mechanism of MoSe2/T20 eliminates the traditional 
problems of one bug-one drug approach and showed broad spectrum nature of designed 
systems. 
3.2.5) Mechanistic study of antibacterial activity of MoSe2/ssDNA 
 We carried out SEM and TEM studies to investigate the effect of MoSe2/T20 
interactions on the cell morphology of gram-positive MRSA and gram-negative A. 
baumannii cells. SEM images of untreated MRSA and A. baumannii samples showed no 
significant morphological changes (Figure 5a and Figure 5g), and TEM images of 
untreated MRSA and A. baumannii showed an intact cytoplasm (Figure 5d-and 5g-). 
SEM images of MRSA and A. baumannii treated at 0.5x MBC (37.5 µg ml-1) of 
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MoSe2/T20 showed formation of small blob-like structures (Figure 5b), which further 
increased in numbers at 1x MBC (75µg ml-1) (Figure 5c) The formation of small blobs on 
cell membrane can be attributed to interactions with the nanomaterial sharp edges, which 
cause breakdown of the cell membrane. TEM images of MRSA and A. baumannii further 
showed TMDC flakes encapsulating and penetrating the cell membranes of bacteria 
(Figure 5e, 5f and 5k, 5i). For both A. baumannii and MRSA, TEM images demonstrated 
the presence of void spaces in cytoplasm after treatment with 0.5x MBC, which further 
increased with increasing nanomaterials concentrations to 1x MBC. The formation of 
small groove-like structures in the cell membrane, leads to disturbance in the cytoplasm 
and finally leakage of protein and other cell components out. With increasing 
nanomaterial concentration, the density of void spaces increases, indicating stronger 
interactions with cell surfaces. The nature of damage to cellular membrane and cytoplasm 
is identical for both gram-positive and gram-negative bacteria, which further supports the 
broad-spectrum antibacterial nature of nanomaterials.  
The microscopic analysis of TMDC-treated bacteria showed void spaces inside 
the cytoplasm of bacteria, which can be attributed to the fact that the TMDC flakes 
caused severe damage to the peptidoglycan of the plasma membranes. The damaged 
membrane in turn fails to hold the turgor pressure of the cytoplasm and leads to leakage 
of the cytoplasm. The observed effect is consistent with other reports of the antibacterial 
mechanism of carbon-based nanomaterials, which act as “nanoknives” that can interfere 
with membrane integrity as a result of their atomically sharp graphene edges.143,163,164 
The theoretical and experimental studies of antibacterial mechanisms of graphene-based 
nanomaterials have shown that they act like blades penetrating through bacterial cell 
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membranes, causing physical damage, and leading to leakage of cytoplasm. Based on 
previous studies, we hypothesize that the presence of DNA on TMDC surfaces increases 
their hydrophilicity, which encourages them to make contact interaction with the outer 
surfaces of the bacteria.147 Once in close proximity, the sharp edges of the MoSe2/T20, 
which are more readily exposed as a result of the conformal ssDNA coating, are better 
able to interfere with the membrane to trigger cell death. 
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Figure 2.5: Microscopic evaluation of morphology of bacteria before and after treatment 
with MoSe2/T20 (a, d) SEM and TEM imaging of MRSA and A. baumannii before 
treatment with nanomaterials. SEM images of MRSA and A. baumannii demonstrate 
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intact morphology of bacterial cell. Also, TEM reveals intact cytoplasm inside bacterial 
cell membrane. (b, e) SEM and TEM images of bacteria after treatment with 0.5 x MBC 
MoSe2/T20. The SEM images demonstrate the appearance of small vacuole-like structure 
on the bacterial membrane due to interactions with sharp edges of bacteria. TEM 
demonstrates disturbance in cytoplasm and small empty void spaces inside bacteria after 
interactions with sharp edges of nanomaterials. (c, f) SEM images demonstrate damaged 
bacterial membrane. TEM images demonstrates creation of void spaces in bacterial 
cytoplasm’s after interactions with MoSe2/T20. 
 
We further evaluated the antibacterial killing mechanism MoSe2/T20 using the 
well-known probe 3,3’-Diethyloxacarbocyanine Iodide (DiOC2). DiOC2 is a cyanine dye, 
which permeates the cell membrane exhibiting green fluorescence, and undergoes 
aggregation in the polarized cell leading to fluorescence shifting from green to red. We 
evaluated the change in membrane potential after nanomaterial interactions on two 
different strains of bacteria, gram-positive S. aureus and gram-negative E. coli. For the 
membrane potential assay, we treated the bacteria at four different concentrations, 1x 
MBC, 0.5x MBC, 0.25x MBC and 0.125x MBC. The carbonyl cyanide 3-
chlorophenylhydrazone, a well-known membrane ionophore was used as a positive 
control. With increasing nanomaterial concentration, the fluorescence shifts towards the 
green channel, which is further evident from lowering of the red/green fluorescence 
intensity ratio. The change in fluorescence intensity ratio indicates that interaction of the 
bacterial cell with nanomaterials triggers depolarization of cell.  
After measuring membrane potentials, we further studied the induction of 
oxidative stress, using the fluorogenic probe CellROX. The oxidative stress induced after 
nanomaterial interactions was studied for both gram-positive S. aureus and gram-
negative E. coli at three different concentrations, 1x MBC, 0.5x MBC and 0.25x MBC. 
At 1xMBC, MoSe2/T20 induces 42-fold and 16-fold higher oxidative stress for S. aureus 
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and E. coli with respect to untreated samples (Figure 4.6 c and 4.6 d). Furthermore, 
oxidative stress of bacterial cell decreases with nanomaterial concentration. The addition 
of antioxidant N-acetylcysteine at 1x MBC of nanomaterial concentrations reduces the 
oxidative stress by 19-fold and 6-fold respectively, which further demonstrates the 
generation of cellular oxidative stress after interactions with nanomaterials.  
After determination of membrane potential and oxidative stress generation in 
bacterial cell, we further evaluated the impact of this stress on DNA damage.  Damage to 
DNA generally triggers programmed cell death. There are two well-known pathways for 
programmed cell death, RecA and mazEF pathways. The mazEF pathways refers to 
toxin-antitoxin module of bacteria. mazF genes generally encode for a toxic 
endoribonuclease protein MazF, which quickly degrades mRNA whereas mazE genes 
lead to secretion of the antitoxin mazE, which neutralizes the effect of MazF. Under 
stressful conditions, MazE is quickly degraded by ClpPA serine protease, which leads to 
the presence of higher toxic protein and in turn cell death. The SOS response pathway 
refers to inducible pathways that are responsible for DNA repair.165 There are two key 
proteins which is responsible for this SOS response pathways, repressor LexA and 
inducer RecA. In absence of DNA damage, LexA dimer binds to palindromic sequence 
of the DNA SOS box, inhibiting expression of RecA genes. Under DNA damage, RecA 
pathway is activated leading to self-cleavage of LexA and activation of RecA pathways, 
which lead to cell death.166  
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Figure 2.6: Mechanistic analysis of antibacterial action of MoSe2/T20 (a, b) Generation of 
oxidative stress after interactions with MoSe2/T20. (c, d) Change in membrane potential 
after interactions with MoSe2/T20 (e) Fold change in mRNA expression after interactions 
with MoSe2/T20 
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We studied the programmed cell death pathways of E. coli after interaction with 
0.5x MBC and 1x MBC of MoSe2/T20. After interactions of nanomaterials with E. coli, 
0.5x MBC and 1x MBC showed 2-fold and 3-fold increase in mRNA expression of RecA 
levels, whereas there is 1-fold increase in mazEF levels for both the tested 
concentrations. These studies clearly demonstrate involvement of two pathways towards 
the cell death after interaction with MoSe2/T20. 
3.2.6) Proposed antibacterial action of MoSe2/T20 
The antibacterial activity of MoSe2-ssDNA can be summarized as a three-step 
process. First, negatively charged DNA on the surface of 2D MoSe2 selectively increases 
the tendency of the bacterial cells to undergo interactions with hydrophobic sharp edges 
of nanomaterials. The sharp edge of nanomaterials undergoes insertion inside bacterial 
cell membrane, leading to rupture of the cell membrane. The rupture to cellular 
membrane in turn induces polarization of cell membrane potential. The alteration of 
membrane potential, in turn induces generation of cellular oxidative stress, causing 
damage to DNA, and finally programmed cell death. Thus, damage to cell membranes is 
a key factor to initiating the process. 
Our study showed MoSe2/ssDNA demonstrated stronger bactericidal activity 
towards gram-positive strains than gram-negative strains at all the concentrations we 
tested. This trend correlates with previously obtained antibacterial activity for carbon-
based nanomaterials.34–39 The difference in killing efficiency between gram-negative and 
gram-positive bacterial strains can be explained by their different outer structures. Gram-
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negative bacteria have outer membranes, which are made up of a lipid bilayer and thin 
peptidoglycan layer, whereas gram-positive bacteria are made up of a thick peptidoglycan 
layer and no outer membrane.167 The outer membrane of gram negative bacteria is made 
up of negatively charged glucosamine disaccharides called lipopolysaccharides, whereas 
gram positive bacteria contain thicker peptidoglycan layer with long anionic polymer 
called teichoic acids threading out from the peptidoglycan layer. The presence of more 
negatively charged surfaces on gram-negative bacteria provides higher resistance to 
negatively charged nanomaterials. Furthermore, the absence of outer membrane on gram-
positive bacteria makes it more susceptible to membrane damage by direct interaction 
with the sharp edges of nanomaterial flakes. The absence of lipopolysaccharides coupled 
with the lack of outer membrane on the surfaces of gram-positive bacteria makes them 
more susceptible to membrane damage by sharp edges of negatively charged 
nanomaterials. 
3.3) Conclusion 
 Using short synthetic ssDNA sequences, we have successfully prepared stable 
dispersions of 2D TMDCs in aqueous solutions and demonstrated their remarkable 
antibacterial performance. Exfoliation of few-layer TMDC nanosheets was confirmed 
using optical absorbance and TEM and AFM imaging. Concentration measurements 
using ICP-MS identified MoSe2 as the TMDC most effectively dispersed using synthetic 
ssDNA. Also, our experimental and computational study showed DNA sequence 
dependence towards dispersing TMDCs, with T20 have the strongest affinity towards 
dispersing TMDCs. Owing to the biocompatibility of the ssDNA coating, we studied the 
effect of the MoSe2 nanosheets encapsulated by T20 ssDNA against human and bacterial 
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cells. While no toxicity was observed against a human cell line, we observed potent 
bactericidal activity for the MoSe2/T20 nanosheets against multiple strains of gram-
negative and gram-positive bacteria. In side by side comparisons, the bactericidal 
efficiency of MoSe2/T20 nanosheets exceeded that of the most widely studied two-
dimensional antibacterial material graphene oxide by more than 1000-fold. Furthermore, 
it exceeded the reported activity of Ti3C2Tx, a recently developed two-dimensional 
antibacterial139, by more than 100-fold and 10-fold against gram-positive and gram-
negative bacteria, respectively. MoSe2 prepared using long single-stranded DNAs or with 
Pluronic F77 coating were much less effective at eliminating the bacteria demonstrating 
the critical importance of an optimized, conformal ssDNA coating for enhanced 
antibacterial activity. Studies of both E. coli and MRSA cells treated with the MoSe2/T20 
revealed that the nanosheets aggressively interact with the cell walls of the bacteria, 
acting as nanoknives that create holes and folds in the membrane to induce cell death. 
Furthermore, it successfully eradicated all the clinical isolates of ‘ESKAPE’ strains, 
which opened up new windows for the development of next generation broad-spectrum 
antibacterial material replacing the tradition strategy of combating these ‘Superbugs’ 
These results not only demonstrate that 2D MoSe2/ssDNA can exhibit antibiotic-
like activity against multidrug resistant bacteria, but also emphasize the importance of 
employing optimized encapsulation agents to enhance the effectiveness of two-
dimensional nanoknives. In particular, the use of a conformal ssDNA coating suggests 
that an array of other biocompatible biomolecules can be interfaced with intrinsically 
antimicrobial 2D nanomaterials to generate effective new tools to combat the growing 
threat of antimicrobial drug resistance. 
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3.4) Methods 
3.4.1) DNA dispersion of nanomaterial 
In a typical experiment, TMDC powder was added to a 5-mL aqueous solution 
containing 1 mg of single-stranded DNA (Integrated DNA Technologies). MoSe2 and 
WSe2 bulk powder (Sigma Aldrich) at a mass of 200 mg was used for each dispersion, 
while a lower mass of 100 mg of MoS2 and WS2 (Sigma Aldrich) led to higher 
concentration dispersions for these compounds. The resulting mixture was ultrasonicated 
with a 13-mm tip f at a power level of 12 W for 2 hours. (Branson Digital Sonifier 450D) 
After ultrasonication, sample was centrifuged at 5000 g for 5 minutes followed by 21000 
g for 1 minute to remove the unexfoliated material. The supernatant of ssDNA-
encapsulated TMDC nanosheets was then carefully decanted for study. 
3.4.2) TEM analysis of DNA dispersed solution 
The sample was prepared using drop casting method. Briefly, 6 µl of dispersed 
solution was drop casted onto holey carbon copper grids and imaged using a Phillips CM-
12 TEM. 
3.4.3) AFM analysis of DNA dispersed solution  
The substrate (SiO2/Si) were cleaned in sequential ultrasonic baths of acetone and 
IPA for 5 minutes, respectively. Then the dispersions of nanomaterials were spin-coated 
onto the substrate at 2500 rpm. The spin coated samples were annealed in vacuum with 
200 sccm of ultrahigh pure argon gas flow at 300 °C for 3 hours to remove the solvent 
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residue. AFM images were taken using a Multimode V system (Bruker inc.) in ScanAsyst 
mode with ScanAsyst-Air tips and flattening was processed using Gwyddion 
3.4.4) Antibacterial studies 
The antibacterial activity of MoSe2-ssDNA was studied using wild type E. coli 
strain MG1655 (ATCC -700926), three E. coli MDR strains (ATCC- BAA-2340, ATCC-
BAA-2469  and ATCC-BAA-2471 ), Staphylococcus aureus (ATCC-29213), Methicillin 
resistant Staphylococcus aureus (ATCC-BAA 1720), Pseudomonas aeruginosa (ATCC- 
BAA 2113), Klebsiella pneumoniae (ATCC- BAA 2342), Vancomycin resistant 
Enterococcus faecium (ATCC-51299), Acinetobacter baumannii (ATCC- BAA 1797) 
and Enterobacter cloacae (ATCC- BAA 2468). LB medium (Sigma Aldrich) and LB agar 
(Sigma Aldrich) were used to grow E. coli strain MG1655. TSB broth (Sigma Aldrich) 
and TSB agar (Sigma Aldrich) were used to grow Staphylococcus aureus, Methicillin 
resistant Staphylococcus aureus, Pseudomonas aeruginosa and Acinetobacter baumannii 
whereas Vancomycin-resistant Enterococcus faecium were grown in BHB broth (Sigma 
Aldrich) and BHB agar (Sigma Aldrich) in the presence of 4 µg/ml of vancomycin. MHB 
broth (Sigma Aldrich) and MHB agar (Sigma Aldrich) was used to grow Klebsiella 
pneumoniae. Single colonies were picked up from the agar plates and allowed to grow 
overnight in 5 ml of culture medium. Then, the sample was diluted 100 times in medium 
and allowed to grow until it reached 0.3 OD. Cultures were centrifuged at 2000 rpm for 
10 minutes, and pellets were washed three times in phosphate buffer saline (PBS, Sigma 
Aldrich) to remove medium constituents. Finally, cell pellets were redispersed in 
autoclaved water and diluted to a cell concentration of 107 CFU/ml. Bacteria at 
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concentrations of 107 CFU/ml were incubated with different concentrations of 
nanomaterials (40-150 µg/ml) for 4 hours. After incubation, bacteria were plated in agar 
plates using serial dilution method and allowed to grow overnight. 
3.4.5) SEM and TEM analysis of bacteria  
For TEM, samples were initially fixed with 2.5% glutaraldehyde overnight at 4 
°C and pelleted into 0.8% aggregate to form dense cell aggregates. The cell pellet was 
treated for 2 hours with 1% Osmium tetraoxide in DPBS, followed by washing with 
deionized water and en-block stained overnight at 4 °C with aqueous 0.5% uranyl acetate. 
The cell pellet was dehydrated in series in a graded acetone series. The sample was 
sectioned and post stained using 2% uranyl acetate in 50% ethanol solution and Sato’s 
lead citrate for 3-4 minutes. Images were acquired using Phillips CM-12 TEM operated at 
80 kV using a Gatan model 791 side-mount CCD camera 
For SEM, samples were initially fixed using 2.5% glutaraldehyde at 4 °C, followed by 
washing with DPBS. The samples were postfixed with 1% osmium tetraoxide in DPBS, 
followed by washing with deionized water and dehydration in graded ethanol series. The 
samples were critically dried, sputtered coated with gold-palladium and images was 
captured using JEOL JSM6300 SEM operated at 15 kV 
3.4.6) Membrane potential assay 
The membrane potential of bacteria was determined following the manufacturer’s 
protocol, Baclight membrane potential kit (Invitrogen). Briefly, bacteria were inoculated 
to mid-log phase and diluted to the order of 106 CFU/ml in autoclaved water. The 
bacteria were treated with different concentrations of MoSe2-ssDNA (1x MBC, 0.5x 
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MBC, 0.25 x MBC and 0.125 x MBC) for 4 hours. A fully depolarized sample was 
prepared on addition of 5 mM proton ionophore, carbonyl cyanide 3-
chlorophenylhydrazone (CCCP). After treatment, samples were incubated with 30 mM 
DiOC2 for 1 hour. Membrane potential was determined using Stratedigm S1300Exi cell 
analyzer equipped with A600 high-throughput autosampler, as ratio of cell exhibiting red 
fluorescence to cell exhibiting green fluorescence. Cell populations were gated based on 
untreated (polarized) and CCCP treated (depolarized) one. 
3.4.7) ROS production assay 
E. coli and S. aureus was inoculated in LB and TSB medium to mid-log phase 
and diluted to the order of 106 in autoclaved water. The samples were treated with 
different concentration of MoSe2-ssDNA (1x MBC, 0.5x MBC, 0.25x MBC) for 4 hours. 
After incubations, cells were stained using CellROX orange reagent (Invitrogen) 
following manufacturer’s protocol. Briefly, samples were stained with 750 mM of 
CellROX orange reagent, and samples was analyzed using Stratedigm S1300Exi cell 
analyzer equipped with A600 high-throughput autosampler and mCherry fluorescence 
output was used to determine the oxidative stress of the cells. 
3.4.8) RNA extraction and reverse transcription polymerase chain reaction (RT-
PCR) for determination of programmed cell death 
The programmed cell death pathway of bacteria was determined using m-RNA 
expression level following the reported protocol. 168 Briefly, bacteria were treated with 
three different concentrations of nanomaterials, 1x MBC, 0.5x MBC and 0.25 x MBC. 
After incubation, the bacteria were centrifuged, and RNA was extracted using 
 
56 
manufactures protocol (Qiagen). After extraction of RNA, reverse transcription was 
performed following manufactures protocol (Qiagen Reverse Transcription kit). After 
extraction of cDNA, RT-PCR was performed using manufactures protocol iTaq 
Universal SYBR Green Supermix (Bio-Rad). The primer used for the RT-PCR: recA 
(fwd) AGATCCTCTACGGCGAAGGT, (rev) CCTGCTTTCTCGATCAGCTT; lexA 
(fwd) GACTTGCTGGCAGTGCATAA, (rev) TCAGGCGCTTAACGGTAACT; 
MazEF-1 (fwd) CTTCGTTGCTCCTCTTGC, (rev) CGTTGGGGAAATTCACCG; 
16SrRNA (fwd) TGTAGCGGTGAAATGCGTAGA, (rev) 
CACCTGAGCGTCAGTCTTCGT. A positive control of genomic DNA and no-reverse 
transcription were included as controls. Cycling was performed in Applied Biosystems 
ViiA 7 Real-Time PCR systems.  
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Chapter 4 
Eradication of multidrug-resistant bacteria using two-dimensional material based 
nanohybrid structures. 
4.1) Introduction 
 
The increasing pervasiveness of infections caused by multidrug-resistant (MDR) 
bacteria is a major global health issue, which has been further exacerbated by the lack of 
effective new antibiotics introduced in last 40 years169,170. Drug-resistant bacteria lead to 
significant morbidity and mortality, with 1.7 million people acquiring MDR infections in 
United States alone and almost 98,987 deaths each year, which is more than the deaths 
annually from prostate cancer, breast cancer, heart failure and diabetes.152,171-173 The 
increasing prevalence of infections from drug-resistant bacteria in hospital settings and 
decreasing effectiveness of antibiotic treatments, severely affect multiple fields of 
medicine, including surgery, premature infant care, cancer chemotherapy and 
transplantation medicine174. The traditional strategy for combating these superbugs 
involves the development of new antibiotics, but only two classes of antibiotics have 
been introduced into the clinics over the past two decades and neither of these were 
effective against a broad spectrum of bacteria.175 Furthermore, the mutation-prone 
replication machinery of bacteria lead to significant development of resistance to any 
introduced therapy that solely relies on bacteriostatic/bactericidal mechanisms, and 
clinically significant resistance can appear within few months of the introduction of a 
new antibiotics176-178. For example, Ceftaroline was introduced in clinics in 2010 and, 
less than a year later, the emergence of resistance was observed in patients with Neisseria 
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gonorrhoeae, Enterobacter and Staphylococcus aureus infections179. The dearth of 
proper antibiotics discovery and rapid resistance development demands the development 
of alternative strategies for combatting bacterial infections.  
Unlike traditional antibiotics which target bacterial intracellular targets180, next 
generations strategies for combating bacteria will involve the development of antibiotics 
which hold the ability to circumvent the resistance-developing machinery of bacteria, 
interfere with alternative antimicrobial target, and demonstrate the ability to eliminate 
multiple strains of bacteria181. Promising candidates in this regards are antimicrobial 
peptides (AMPs)182, AMP cationic analogues183 and nanoantibiotics184. AMPs are short 
cationic peptides of used as a natural defense mechanism185, which hold the ability to 
specifically target bacterial cell membranes using electrostatic interactions, leading to 
disruptions of cell membranes and finally cell death.182,186. Despite successes in 
eliminating a broad spectrum of drug resistant bacteria, the implementations of AMPs 
and AMPs cationic analogues in healthcare settings is significantly hindered by their 
tendency to undergo non-specific interactions with mammalian cells, which in turn 
imparts significant toxicity186-188. Furthermore, high production cost and tendency to 
undergo degradation in the presence of proteases, further hinder implementation of AMPs 
as next-generation antibiotics.189 The other strategy, nanoantibiotics, refers to the use of 
nanotechnology for development of antibacterial materials that include nanoparticles, 
metal and metal oxides, carbon-based materials, and surfactant-based emulsions for 
eradication of superbugs168,183,184,190,191. The high surface-to-volume ratio and unique 
chemico-physical properties of nanomaterials are the two key factors that contribute to 
eradication of multidrug-resistant bacteria.192-194 Furthermore, multiple antibacterial 
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mechanisms of nanoantibiotics, such as the disruption of bacterial cell membranes, 
generation of oxidative stress, make them highly effective against multiple strains of 
bacteria and inhibits the resistance development machinery.191,193-195 Despite of its 
success as an antibacterial candidate, the high toxicity and lack of effective formulation 
strategies hinder the application of nanoantibiotics.196 Also, most of the reported 
antimicrobial systems are highly efficient against planktonic bacteria, but fail to function 
against biofilms. To the best of our knowledge, antibacterial materials systems which is 
highly effective against both planktonic bacteria and biofilms, easy to construct, and 
biocompatible towards mammalian and red blood cells cell have not been reported.  
To overcome these challenges, we integrated two antimicrobial components, 
AMPs and nanoantibiotics in a single nanotechnology platform and applied them 
synergistically to combat multidrug-resistant bacteria. In this chapter, we report the 
engineering of a new class of antimicrobial agents, consisting of cationic polypeptides, 
poly-L-lysine (PLL) encapsulating the two-dimensional transition metal dichalcogenide 
MoSe2. Incorporation of the polypeptide PLL on the nanomaterial surface reduces non-
specific peptide interactions with mammalian cells while facilitating specific interactions 
with the negatively charged, bacterial cell membrane. We hypothesize the presence of 
cationic peptides on the hydrophobic two-dimensional surface increases the local 
concentrations of cationic moieties, which imparts stronger force on bacterial cell 
membrane making it more efficient than individual components alone. For further 
stabilization in high salt concentrations of biological systems, we incorporated the block 
copolymer Pluronic F77 along with PLL on the surface of MoSe2, which provided steric 
stabilization to these systems.  
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The designed MoSe2/PLL/F77 systems were highly efficient in eradicating both 
gram-positive and gram-negative, ‘ESKAPE’ strains, with minimum bactericidal 
concentrations lower than 50 µg/ml. Furthermore, MoSe2/PLL/F77 systems showed 
minimal to no toxicity towards both red blood and mammalian cells. Our studies also 
revealed MoSe2/PLL/F77 can successfully penetrate and eradicate biofilms, while 
maintaining biocompatibility towards mammalian cells. Also, when tested in co-culture 
systems, MoSe2/PLL/F77 showed 100% eradication of planktonic bacteria and 3-log 
reductions in biofilms while posing no toxicity towards mammalian cells. Unlike 
conventional antibiotics, MoSe2/PLL/F77 did not show any significant generation of 
resistance towards gram-positive S. aureus and gram-negative P. aeruginosa after 20 
serial passages. Furthermore, mechanistic evaluation of antibacterial actions of 
MoSe2/PLL/F77 demonstrated multimodal antibacterial mechanism which includes 
electrostatic interactions with bacterial cell membrane, followed by disturbance to 
membrane potential, oxidative stress and finally cell death. Overall, we have developed a 
new nanoengineered polypeptide/2D inorganic material antibacterial that can eradicate 
planktonic bacteria and biofilms without posing significant toxicity to mammalian and 
red blood cells. 
4.2) Results and discussion 
4.2.1) Designing of antibacterial systems 
Inspired by previous antibacterial mechanism of naturally occurring cationic peptide197-
199, we selected the commercially available cationic polypeptide poly-L-lysine (PLL) and 
peptide to interface with 2D MoSe2 nanosheets. We hypothesized that the dual 
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amphipathic and cationic nature of PLL would perform two function: first, its cationic 
nature would assist in interactions with negatively charged bacterial cell membrane, and 
second, its amphiphilic nature would enable to stably encapsulate the two-dimensional 
transition metal dichalcogenide MoSe2. MoSe2 was ultrasonicated in the presence of PLL 
in the weight ratio of 20:1 for 2 hours. During this process, the cationic polypeptides 
undergo intercalation between layers of MoSe2, weakening the van der Waals 
interactions, and assisting the exfoliation of MoSe2; whereas the presence of polycationic 
peptides on the surface of MoSe2 further stabilizes the nanomaterials in solution phase 
via electrostatic repulsion. The zeta potential of PLL dispersed MoSe2 was +41 mV, 
which indicated presence of electrostatic repulsion as a key factor towards stabilization of 
flakes in colloidal dispersion.  
Despite of high stability of PLL-dispersed MoSe2 in colloidal dispersion, PLL-
dispersed MoSe2 underwent deleterious electrostatic interactions in high salt 
concentrations of buffer medium, which in turn led to aggregation of the nanosheets. To 
further stabilize this system in buffer media, we supplemented PLL on the surface of the 
nanosheets with the block copolymer Pluronic F77, which in turn provided additional 
stabilization to nanosheets using steric repulsion. To further confirm the replacement of 
PLL, the zeta potential of the colloidal dispersion was measured and showed reduction of 
zeta potential from + 41 mV to +21 mV (Figure S1). Furthermore, the MoSe2/PLL/F77 
hybrid structure was found to be stable in wide range of buffers, including M9, MEM and 
1x PBS. After successful stabilization of MoSe2 nanosheets using PLL and Pluronic-F77, 
excess polymer was removed from the solutions using dialysis. After purification, 
MoSe2/PLL/F77 dispersion was characterized using UV-Vis spectroscopy, which showed 
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presence of two excitonic peaks. The presence of the excitonic peaks indicated that the 
MoSe2 remained in its pristine 2H phase after exfoliation. We further evaluated the 
morphology of nanomaterial using transmission electron microscopy (TEM) and atomic 
force microscopy (AFM). The morphological analysis of MoSe2/PLL/F77 using TEM, 
demonstrated successful exfoliation and thin-flake like structure of dispersed 
nanomaterial with lateral dimension in the range of 50-100 nm. The polymer content on 
the surface of MoSe2 was further determined using Thermogravimetric analysis (TGA). 
The TGA analysis of MoSe2/PLL/F77 demonstrated presence of 22% polymer on the 
surface of MoSe2. (Figure S2) 
4.2.2) In vitro antibacterial activity of MoSe2/PLL/F77 
After successful preparation and characterization of MoSe2/PLL/F77, we evaluated the 
antibacterial efficiency of MoSe2/PLL/F77 against two model bacterial strains, gram-
positive S. aureus and gram-negative E. coli K12 MG1655, by determining minimum 
bactericidal concentrations (MBC). The MBC refers to the lowest concentrations of an 
antibacterial required to achieve 100% elimination of bacteria. Antimicrobial assays for 
determination of MBC were conducted in minimal essential medium (MEM). For MBC 
determination, bacteria were initially treated with MoSe2/PLL/F77 for 4 hours, 200 
followed by plating in agar and incubation for 24 hours at 37 °C. The MBC for 
MoSe2/PLL/F77 was 25 µg/ml for gram-negative E. coli and 50 µg/ml for gram-positive 
S. aureus. For comparison, we also tested the antibacterial efficiency of MoSe2/PLL and 
PLL under the same conditions. The MoSe2/PLL underwent aggregations in MEM 
medium within few minutes of additions and no antibacterial action was observed. For 
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comparison to PLL, we used TGA studies to determine that PLL and Pluronic F77 
comprised overall 22% of the MoSe2/PLL/F77 mass. Since both polymers, PLL and 
Pluronic-F77 showed same TGA signature, it was not possible to isolate the 
concentrations of the individual polymers. For our comparison studies, we eliminated the 
contribution from Pluronic-F77 and used 22% as PLL concentrations for further studies. 
On treatment with same concentrations of PLL as present on the surface of 
MoSe2/PLL/F77, we observed PLL delayed the growth of bacteria on agar plates but did 
not show any significant killing under the same treatment conditions.  
 
Figure 1: Schematic and characterization of MoSe2/PL/F77 (a) Schematic demonstrating 
the exfoliation and dispersing MoSe2 in the presence of poly-L-lysine and Pluronic-F77 
(b) TEM image demonstrating the nanosheet like morphology of MoSe2/PL/F77 (c) AFM 
images demonstrating the thin nanosheet like morphology. 
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Figure 3.2: Antibacterial activity, immunogenicity and biocompatibility determination of 
MoSe2/PLL/F77 (a) Minimum bactericidal concentrations of MoSe2/PLL/F77 on gram-
negative ‘ESKAPE’ bacteria (b) Minimum bactericidal concentrations of 
MoSe2/PLL/F77 on gram-positive ‘ESKAPE’ bacteria (c) Determination of TNFa 
expression of RAW 264.7 cells in the presence of MoSe2/PLL/F77. Lipopolysaccharides 
(LPS) was used as a positive control (d) Haemolysis of human red blood cell on 
treatments with MoSe2/PLL/F77. 
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After successful demonstration of the antibacterial activity of MoSe2/PLL/F77 on 
model systems, we further extended our antibacterial studies towards multidrug-resistant 
(MDR) pathogenic ‘ESKAPE’ bacterial strains. The ‘ESKAPE’ strains represent a 
multidrug-resistant group of bacteria family that are prone to develop resistance to 
commonly used antibiotics201. The lack of proper antibiotics for treating ‘ESKAPE’ 
strains makes them one of the biggest threats to hospitals and clinics. The challenges 
posed by these MDR strains in clinical settings inspired us to test the antibacterial 
efficiency of our designed systems on these bacterial strains. The MBC of 
MoSe2/PLL/F77 was determined for the ‘ESKAPE’ strains using the same strategy as the 
model systems. MoSe2/PLL/F77 successfully eliminated both gram-positive and gram-
negative strains at 50 µg/ml, Figure 2 (a) and Figure 2 (b). The same MBC values for all 
the bacterial strains implied that antibacterial action of MoSe2/PLL/F77 is independent of 
bacterial species. Furthermore, same MBC value for P. aeruginosa and K. pneumoniae 
was surprising as both the species possess a thick extracellular capsule202,203, which 
contributes towards low permeability of antibiotics and makes treatment difficult. The 
species-independent antibacterial action of MoSe2/PLL/F77 eliminates the traditional 
problem of one drug-one bug approach of traditional therapy. 200 
4.2.3) Biocompatibility of MoSe2/PLL/F77  
After successful in vitro antibacterial evaluation of MoSe2/PLL/F77, we tested the 
biocompatibility of MoSe2/PLL/F77 in two different cell lines, human red blood cells 
(RBC) and rat macrophage RAW 264.7 cells. We tested the compatibility of 
MoSe2/PLL/F77 on human red blood cell using haemolysis assays. The haemolysis assay 
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measures the toxicity of different compounds against red blood cells by determining the 
extent of cell lysis upon interaction with different molecules. We investigated the 
hemolytic activities of MoSe2/PLL/F77 on human RBC by incubating cells at different 
concentrations of MoSe2/PLL/F77 for 2 hours. After incubation with MoSe2/PLL/F77, no 
significant haemolysis was observed, with only 30% hemolysis of red blood cells 
observed at concentrations as high as 200 µg/ml (4x MBC), Figure 2(e). Concentrations 
which cause less than 50% haemolysis of red blood cells are considered 
haemocompatible.183 After successful determination of hemocompatibility, we further 
determined the biocompatibility of MoSe2/PLL/F77 on rat macrophage cell, RAW 264.7. 
The cytotoxicity of MoSe2/PLL/F77 was determined using an alamerBlue cell 
proliferation assay. This fluorometric assay measures the metabolic activity of cells based 
on oxidation-reduction chemistry and it undergoes oxidation from non-fluorescent form 
to fluorescent form204. On treatment with MoSe2/PLL/F77 at a concentration as high as 
200 µg/ml (4x MBC), no significant toxicity was observed for the RAW-264.7 cells.  
We further tested the chronic toxicity of MoSe2/PLL/F77 using inflammatory 
cytokine responses from macrophage RAW 264.7, Figure 2 (c). The macrophage RAW 
264.7 cells were incubated with MoSe2/PLL/F77 and the immune response was measured 
using tumor necrosis factor alpha (TNF-a) cytokine expression205. After incubations at 
200 µg/ml (4x MBC) with MoSe2/PLL/F77, no TNF-a expression was observed. The 
absence of TNF-a expression at 200 µg/ml, clearly demonstrates in vitro immune 
compatibility with mammalian immune cells. The MoSe2/PLL/F77 studies on red blood 
cells and RAW-264.7 cells clearly demonstrated hemocompatibility, biocompatibility and  
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immune compatibility of our designed systems.  
4.2.4) In vitro biofilms and persister eradication using MoSe2/PLL/F77 
After successful in vitro antibacterial and biocompatibility evaluations, we further 
extended our studies and evaluated the antibacterial efficiency of MoSe2/PLL/F77 on 
biofilms of both gram-negative A. baumannii and gram-positive S. aureus. Bacterial 
biofilms develop an extracellular matrix, which in turn inhibits the penetration of 
antibiotics206. Furthermore, bacteria in biofilms also employ multiple defense 
mechanisms, including limited nutrient use, slow growth and adaptive stress response, 
which all make them harder to treat using traditional strategies207,208. To investigate the 
effect of these defenses on the nanosheet system, we evaluated the antibiofilm efficiency 
of MoSe2/PLL/F77 on gram-negative A. baumannii and gram-positive S. aureus. 
MoSe2/PLL/F77 completely eradicated biofilms of both gram-positive S. aureus and 
gram-negative A. baumannii bacteria at 200 µg/ml concentrations. Unlike traditional 
therapy, the strong cationic and hydrophobic nature of MoSe2/PLL/F77 favors the 
adhesion and breakdown of extracellular matrix, which in turn led to the elimination of 
bacteria from the biofilms. After successful elimination of biofilms, we further evaluated 
the activity of MoSe2/PLL/F77 against biofilms of persisters. Persisters represent the 
dormant subpopulation of microbial populations, with higher tolerance towards 
antibiotics than regular cells209. For deriving persister cells from biofilms, the biofilms 
were exposed to rifampicin (100x MIC). After exposure to rifampicin for 24 hours, the 
biofilms were washed with 1x PBS to remove the planktonic dead bacteria, and persisters 
were treated with different concentrations of MoSe2/PLL/F77 for 4 hours and cell 
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viability was determined on TSB agar plates. 200 µg/ml of MoSe2/PLL/F77 showed 
100% elimination of biofilm persisters, Figure 3 (b). 
After successful eradication of biofilms, we further evaluated the antibiofilm 
efficiency of MoSe2/PLL/F77 in the presence of HEK 293 human embryonic cells. The 
eradication of biofilms from human tissues and organs is greatly hampered by the toxicity 
imposed by the antibacterial systems towards human cells.210 Before testing the 
MoSe2/PLL/F77 efficiency in co-culture systems, we first tested the cytotoxicity of 
MoSe2/PLL/F77 towards mammalian HEK 293 cells. No significant cytotoxicity was 
observed for HEK 293 at all the tested concentrations of MoSe2/PLL/F77, Figure 4 (c). 
To test the antibiofilm efficiency of MoSe2/PLL/F77 in the presence of human cell, we 
designed an in vitro biofilm co-culture system of gram-negative MDR P. aeruginosa 
bacteria and HEK 293 mammalian cells. For designing of in-vitro co-culture systems, P. 
aeruginosa was seeded on confluent HEK 293 cells and allowed to grow overnight to 
form a biofilm layer. After biofilm formation with HEK 293, the co-culture system was 
treated with range of MoSe2/PLL/F77 concentrations for 6 hours and the cell viability of 
both bacteria and mammalian cells was determined. The MoSe2/PLL/F77 showed 
reduction of biofilm viability at all the treated concentrations with a maximum 4-log 
reduction at 200 µg/ml, without causing any significant toxicity to mammalian cells, 
Figure 4 (d).  
After successful removal of biofilms from co-culture systems, we further 
evaluated the antibacterial actions of MoSe2/PLL/F77 towards planktonic gram-positive 
S. aureus and gram-negative A. baumannii in the presence of HEK 293 cells. The 
confluent HEK 293 cells were seeded with 106 bacteria, and then in vitro co-culture 
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systems were treated with range of MoSe2/PLL/F77 concentrations for 4 hours and cell 
viability of both mammalian cells and bacteria was evaluated. MoSe2/PLL/F77 showed 
reductions of both bacteria with 100% eradications at 200 µg/ml. The ability of 
MoSe2/PLL/F77 to eradicate planktonic bacteria and biofilms in the presence of 
mammalian cells makes them promise next generation antibacterial systems for inhibiting 
the MDR infections caused by surgical instruments and implants.  
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Figure 3. 3: Biofilm eradication efficiency of MoSe2/PLL/F77 towards biofilms gram-
positive and gram-negative bacteria and in co-culture systems of bacteria and mammalian 
cells. (a) Minimum biofilm eradication concentrations of gram-positive S. aureus and 
gram-negative A. baumannii (b) Minimum bactericidal concentrations for persisters from 
biofilms. (c) Cell viability assay of MoSe2/PLL/F77 towards HEK 293. (d) Biofilm 
eradication concentrations of MoSe2/PLL/F77 for P. aeruginosa in the presence of HEK 
293 (e) Eradication of gram-negative A. baumanni using MoSe2/PLL/F77 in a co-culture 
of HEK 293 and bacteria. (f) Eradication of gram-positive S. aureus using 
MoSe2/PLL/F77 in co-culture model of HEK293 and bacteria. 
4.2.5) Antibacterial mechanistic analysis of MoSe2/PLL/F77 
After successful evaluation of antibacterial efficiency, we analyzed the antibacterial 
mechanism of MoSe2/PLL/F77 using scanning electron microscopy (SEM) and TEM. 
We analyzed morphology of gram-negative bacteria, A. baumannii and gram-positive S. 
aureus before and after treatment with 1x MBC of MoSe2/PLL/F77. Both the bacterial 
strains showed intact morphology before treatment, Figure 4 (a, e). After treatment with 
1x MBC of MoSe2/PLL/F77, the bacterial cell membrane demonstrated the formation of 
small blob-like structure on the surface of bacterial membrane, Figure 4 (b, f). This effect 
can be attributed strong electrostatic interactions of the positively charged 
MoSe2/PLL/F77 with negatively charged phospholipids of the bacterial outer membrane, 
which led to the generation of physical stress on the membrane. After analysis of 
bacterial morphology using SEM, we further analyzed the bacterial cytoplasm before and 
after treatment with MoSe2/PLL/F77. Prior to treatment, TEM showed intact cytoplasm 
Figure 4 (c, g), whereas bacteria after treatment showed leakage of cytoplasm from cell 
(Figure 4 (d, h)), further evidence of strong interactions between the MoSe2/PLL/F77 and 
the bacterial cell membrane. 
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Figure 3.4: Microscopic evaluation of antibacterial mechanism of MoSe2/PL/F77 (a,e) 
Scanning electron microscopy (SEM) image of gram-negative Acinetobacter baumannii 
and gram-positive MRSA before treatment, demonstrating  intact cell membrane of 
bacteria (b,f)  SEM  image of gram-negative Acinetobacter baumannii and gram-positive 
MRSA after  treatment with MoSe2/PL/F77, demonstrating damage to  cell membrane 
after interactions with MoSe2/PL/F77 ( c,g) Transmission electron microscopy (TEM) 
image of gram-negative Acinetobacter baumannii and gram-positive MRSA  before 
treatment, demonstrating intact cytoplasm. (d,h) Transmission electron microscopy 
(TEM) image of gram-negative Acinetobacter baumannii and gram-positive MRSA 
after  treatment, demonstrating disturbed cytoplasm and protein leakage 
 
After microscopic evaluations of antibacterial mechanism, we further studied the 
extent of cell permeabilization induced by MoSe2/PLL/F77 using the propidium iodide 
(PI) assay. Bacteria were incubated with propidium iodide (PI) after treatment with 
MoSe2/PLL/F77 and analyzed using flow cytometry. PI is a red-fluorescent stain, which 
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is impermeable to living cells, whereas it permeates the membrane of damaged cells and 
intercalates with DNA, giving red fluorescence. After treatment with MoSe2/PLL/F77, 
bacteria showed membrane damage at all treated concentrations, with highest membrane 
damage at 50 µg/ml (1x MBC). The MoSe2/PLL/F77 showed 92.2% membrane damage 
for A. baumannii whereas 82.71% damage for S. aureus, Figure 5 (a, b). Less than 100% 
membrane damage at 1x MBC for both strains, can be attributed to the fact that some of 
the bacteria underwent complete lysis, and this subpopulation of bacteria cannot be 
detected using our assay conditions.  
After determination of membrane damage, we further evaluated the impact of 
membrane damage on the transmembrane potential of bacteria. The potential across the 
bacterial membrane potential of bacterial membrane facilitates the transport of ions, 
nutrients and biological molecules through the membrane. We incubated both gram-
positive S. aureus and gram-negative A. baumannii with MoSe2/PLL/F77, and the 
membrane potential was determined using the probe DiOC2. DiOC2 exhibits green 
fluorescence for depolarized cells whereas it undergoes self-association in hyperpolarized 
cells causing fluorescence shifts from green to red211. The treatment of both strains of 
bacteria with MoSe2/PLL/F77, induces polarization to bacterial cell with membrane 
potential shifting from hyperpolarized to depolarized with increasing concentrations, 
Figure 5 (c, d). From these studies, we hypothesized that cationic MoSe2/PLL/F77 
undergoes strong electrostatic interactions with negatively charged bacterial cell 
membranes, which result in membrane damage followed by polarization of bacterial cell 
membrane and in turn led to unregulated ion movement and membrane potential 
dissipation. To further prove the hypothesis of electrostatic interactions as a key 
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antimicrobial mechanism, we carried out a competitive inhibition assay with E. coli 
lipopolysaccharides (LPS). For the competitive inhibition assay, MoSe2/PLL/F77 was 
first incubated with varying concentrations of LPS, and a co-mixture of 0.5 x MBC of 
MoSe2/PLL/F77 and LPS was further used for treating E. coli. With increasing 
concentrations of LPS, the antibacterial efficiency of MoSe2/PLL/F77 decreased, and this 
can be attributed to the fact that that cationic nature of MoSe2/PLL/F77 is being 
neutralized with negatively charged LPS, which in turn led to decreases in the 
antibacterial efficiency of MoSe2/PLL/F77, Figure 5 (f).  
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Figure 3.5: Mechanistic analysis of antibacterial action of Microscopic evaluation of 
antibacterial mechanism of MoSe2/PL/F77 using microbiological assays (a,b) PI (%) cells 
demonstrating membrane damaged cells of gram-negative Acinetobacter baumannii and 
gram-positive S. aureus after interactions with MoSe2/PL/F77 (c,d) Change in membrane 
potential after interactions with MoSe2/PL/F77 for gram-negative Acinetobacter 
baumannii and gram-positive S. aureus (e) The change in bactericidal efficiency of 
MoSe2/PL/F77 towards E.coli MG1655 in the presence of bacterial lipopolysaccharides 
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4.2.6) Resistance development study of bacteria against MoSe2/PLL/F77 and 
antibiotics 
The prolonged exposure to particular antibiotics has generally led to the 
development of resistance, which in turn makes them ineffective for long term use. We 
thus performed longer term exposure studies to investigate the potential of bacteria to 
develop resistance to MoSe2/PLL/F77, poly-L-lysine and clinically used antibiotics. We 
studied resistance development on two different well-known clinical strains, gram-
positive S. aureus and gram-negative P. aeruginosa. In these experiments, bacteria were 
treated with antibiotics for 16 hours, MIC was determined and bacteria from sub-MIC 
concentrations was further harvested for next study. The study was carried out for 20 
serial passages over a period of approximately three weeks. As shown in Figure 6 (a, b), 
no resistance development was observed for MoSe2/PLL/F77 after 20 serial passages. In 
contrast, both strains of bacteria developed resistance to cationic polypeptide, poly-L-
lysine. After 8 passages, a 4-log dosage increase was observed for both S. aureus and P. 
aeruginosa. Furthermore, we evaluated the development of bacterial resistance against 
clinically used antibiotics. For P. aeruginosa, we treated the bacteria with two clinically 
used last resort antibiotics, imipenem and gentamicin. The bacteria quickly developed 
resistance to both these antibiotics, with more than 4-log increase in dosage after the 10th 
passage. Similarly, we tested the resistance development of S. aureus against clinically 
used antibiotic, rifampicin. The bacteria developed resistance to the rifampicin, with 
more than 4-log increase in dosage after the 8th passage. Unlike traditional antibiotics, the 
presence of electrostatic interactions and ability to physically disrupt the cell membrane  
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of MoSe2/PLL/F77 enables it to remain effective against evolving bacteria.  
 
Figure 3. 6: Resistance study of MoSe2/PL/F77 towards gram-positive and gram-negative 
S. aureus and P. aeruginosa (a) Development of resistance by Pseudomonas aeruginosa 
against multiple last-resort antibiotics (imipenem, gentamicin), the cationic polymer 
poly-L-lysine and MoSe2/PL/F77 after treatment at sub-MIC concentrations. (b) 
Development of resistance by Staphylococcus aureus against the last-resort antibiotic 
rifampin, poly-L-lysine and MoSe2/PL/F77 after treatment at sub-MIC concentrations.	
4.2.7) Proposed antibacterial mechanism of MoSe2/PLL/F77 
Unlike cationic peptides (monomeric form), the cationic PLL-encapsulated 
MoSe2 nanosheet, increases the local concentrations of positive charges, and the 
MoSe2/PLL/F77 system imparts stronger electrostatic force of interaction compared to 
monomeric polypeptide systems. This study can further be correlated with previous 
studies, which showed integration of polypeptides in a fixed geometry increases the 
antibacterial efficiency168,212. MoSe2/PLL/F77 first binds with LPS, imparts a strong 
electrostatic force of interactions, which in turn lead to destabilization of outer membrane 
and fragmentation of the bacterial membrane. The effect triggers polarization of the cell 
membrane potential, which in turn led to unregulated ion movement. Furthermore, at 
high concentrations of MoSe2/PLL/F77, the force of interaction is so strong that it leads 
to direct cell lysis. This order of interactions is supported by electron microscopy 
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measurements and bioassays. The fragmentation of cytoplasmic membrane is a key factor 
which triggers cell death. Furthermore, presence of strong electrostatic forces in 
MoSe2/PLL/F77 systems, aids in the breaking of the biofilm matrix and removal of 
bacteria from biofilms.  
4.3) Conclusion 
We successfully designed and fabricated a novel therapeutic antibacterial 
platform that can combat multidrug-resistant planktonic bacteria and biofilms using a 
multimodal antibacterial mechanism. The designed systems target the bacterial cell 
membrane using electrostatic interactions, which in turn led to deformation of cell 
membrane, polarization of the cell, cytoplasmic leakage and finally cell death. 
Furthermore, the designed system was successful in eliminating both biofilms and 
persisters. It specifically and efficiently eradicated biofilm and planktonic bacteria from a 
co-culture system of bacteria and mammalian cell. Unlike traditional antibiotics, no 
development of resistance was observed by bacteria after 20 serial passages.  
4.4) Methods 
4.4.1) Dispersion of MoSe2 in Poly-L-Lysine (PLL) and Pluronic-F77 
In a typical experiment, 0.2 mg of MoSe2 (Sigma Aldrich) was added to a 5-ml 
aqueous solution containing 10 mg of PLL (Sigma Aldrich). MoSe2 bulk powder was 
ultrasonicated with a 13-mm tip at a power level of 12 W for 2 hours (Branson Digital 
Sonifier 450D). After ultrasonication, the sample was centrifuged at 5000 g for 5 minutes 
followed by 21,000 g for 1 minute to remove the unexfoliated flakes. The supernatant of 
PLL-encapsulated MoSe2 was then carefully decanted. The solution was further 
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ultrasonicated for 30 minutes with 0.5% Pluronic-F77 (BASF) for 30 minutes. The 
resulting solution was than dialyzed for 72 hours, using 100 kD molecular cut off 
cellulose ester membrane. The dialyzed solution was then used for further study. 
4.4.2) TEM analysis of MoSe2/PLL/F77 
The sample was prepared using drop casting method. Briefly, 6 µl of dispersed 
solution was drop casted onto holey carbon copper grids and imaged using a Phillips CM-
12 TEM. 
4.4.3) Antibacterial studies  
The antibacterial activity of MoSe2/PLL/F77 was studied using the wild-type E. 
coli strain MG1655 (ATCC-700926), Staphylococcus aureus (ATCC-29213), methicillin-
resistant Staphylococcus aureus (ATCC-BAA 1720), Pseudomonas aeruginosa (ATCC- 
BAA 2113), Klebsiella pneumoniae (ATCC- BAA 2342), vancomycin-resistant 
Enterococcus faecium (ATCC-51299), Acinetobacter baumannii (ATCC- BAA 1797) 
and Enterobacter cloacae (ATCC- BAA 2468). LB medium (Sigma Aldrich) and LB 
agar (Sigma Aldrich) were used to grow E. coli strain MG1655. TSB broth (Sigma 
Aldrich) and TSB agar (Sigma Aldrich) were used to grow Staphylococcus aureus, 
Methicillin resistant Staphylococcus aureus, Pseudomonas aeruginosa and Acinetobacter 
baumannii whereas Vancomycin-resistant Enterococcus faecium were grown in BHB 
broth (Sigma Aldrich) and BHB agar (Sigma Aldrich) in the presence of 4mcg/ml of 
vancomycin. MHB broth (Sigma Aldrich) and MHB agar (Sigma Aldrich) was used to 
grow Klebsiella pneumoniae. Single colonies were picked up from the agar plates and 
allowed to grow overnight in 5 ml of culture medium. Then, the sample was diluted 100 
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times in medium and allowed to grow until it reached 0.3 OD. Cultures were centrifuged 
at 2000 rpm for 10 minutes, and pellets were washed three times in phosphate buffer 
saline (PBS, Sigma Aldrich) to remove medium constituents. Finally, cell pellets were re 
dispersed in Minimal essential medium and diluted to a cell concentration of 107 CFU/ml. 
Bacteria at concentrations of 107 CFU/ml were incubated with different concentrations of 
nanomaterials (0.625-100 µg/ml) for 2 hours. After incubation, bacteria were plated in 
agar plates using serial dilution method and allowed to grow overnight. 
4.4.4) Haemolysis assay 
Citrate-stabilized fresh human red blood cells (RBCs) were purchased from VWR 
and processed as soon as received. Fresh RBCs were diluted in 1x PBS, centrifuged at 
5000g for 5 minutes. The supernatant was collected, and pellet was redispersed in 1x 
PBS. This step was repeated 4 times to remove any haemoglobin from lysed cell. After 
washing, the cell was redispersed in 1x PBS and diluted to a final concentration of 2 x 
107 cell/ml. The diluted cell was than incubated with varying concentrations of 
nanomaterials in a humidified atmosphere containing 5% CO2 at 37 °C for 2 hours. After 
incubation, solution was centrifuged, and absorbance of supernatant was measured at 570 
nm. RBC suspension in 1x PBS was used as a negative control whereas RBC lysed with 
0.5% Triton X-100 was taken as a positive control. 
4.4.5) Mammalian cell culture  
Rat macrophage 264.7 cell and human embryonic kidney cells HEK 293 were 
purchased from ATCC. Both the cell line was cultivated in DMEM medium containing 
10% FBS and 1% antibiotics. The cells were cultured in a humidified atmosphere 
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containing 5% CO2 at 37 °C. The cells were passaged thrice a week before performing 
cell experiments. 
4.4.6) Determination of TNF alpha expression study of RAW 264.7 macrophage cell 
3 x 104 order of RAW macrophage 264.7 cell was seeded in 96-well plate in a 
humidified atmosphere in 5% CO2 at 37 °C for 24 hours. The cells were treated with 
varying concentrations of nanomaterials for 4 hours. After 4 hours of treatment with 
nanomaterial, solution was removed and replaced with fresh medium. The cell was 
further incubated for 24 hours. After 24 hours, the culture media was collected, and TNF-
a measurement was carried out using ELISA kit. 100 ng/ml of lipopolysaccharide was 
used as a positive control. The experiment was performed in quadruplicate. 
4.4.7) Determination of cell viability of mammalian cell 
Cell viability was determined on both RAW 264.7 and HEK 293 cells. 
Approximately 3 x 104 cell were pre-seeded in 96 well plate. The cell was grown in 
humidified atmosphere in 5% CO2 at 37 °C for 24 hours. The cells were incubated with 
varying concentrations of nanomaterials for 24 hours. After incubations, supernatant was 
removed and replaced with 10% Alamer blue solution in DMEM. After 4 hours 
incubation with 10% alamer blue solution, the fluorescence was measured 
(excitation/emission: 560 nm/610nm). Cells without nanomaterials were considered as 
100% viable. All experiments were performed in quadruplicate. 
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4.4.8) Biofilm formations and treatment 
Single colonies of Acinetobacter baumannii (ATCC- BAA 1797) and 
Staphylococcus aureus (ATCC-BAA 1720) were inoculated in brain heart infusion broth 
and allowed to grow overnight at 37 °C. The overnight culture was diluted and allowed to 
grow, until it reaches an O.D of 0.3. The log-phase bacteria were 100-fold diluted in TSB 
medium, transferred to a 96-well propylene plate, incubated in humidified atmosphere for 
24 hours without shaking. After 24 hours, each well was washed with 1x PBS to remove 
any planktonic bacteria. The washing step was carried out thrice. After washing, biofilm 
was treated with nanomaterial in MEM medium for 4 hours. After 4 hours of treatment, 
the well was again washed with 1x PBS. The 96-well plate was than bath sonicated for 10 
minutes, serial diluted in 1x PBS and plated on TSB agar plates. The TSB agar plates was 
than incubated at 37 °C for 12 hours and colony was counted. 
4.4.9) Determination of antibacterial activity against persisters 
Persister cells were obtained from biofilms following the reported protocol 186. 
The mid-logarithmic growth-phase culture of Staphylococcus aureus (ATCC-BAA 1720) 
and Acinetobacter baumannii (ATCC- BAA 1797) were further diluted in brain heart 
infusion broth and transferred in 96 well propylene plates. The 96 well propylene plates 
were incubated in humidified atmosphere for 24 hours without shaking. After 24 hours, 
each well was washed with 1x PBS to remove planktonic bacteria. Each well was further 
treated with 100 µl of brain heart infusion broth containing rifampicin (3.125 µg/ml) for 
24 hours. After 24 hours treatment, each well was washed with 1x PBS to remove dead 
planktonic bacteria. The plate was bath sonicated to dislodge the persisters. The persisters 
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were than treated with varying concentrations of nanomaterials for 4 hours, serially 
diluted in 1x PBS and plated on TSB agar plates. The TSB agar plates was incubated for 
12 hours at 37 °C and colony was counted. 
4.4.10) Co-culture of bacteria with mammalian cells 
Approximately 3 x 104 HEK 293 cells were pre-seeded in a 96-well plate. The 
cell was grown in a humidified atmosphere in 5% CO2 at 37 °C for 24 hours. The mid-
logarithmic growth-phase culture of Staphylococcus aureus (ATCC-BAA 1720) and 
Acinetobacter baumannii (ATCC- BAA 1797) were centrifuged and redispersed in 
DMEM. The medium was removed from the 96-well plate and substituted with bacteria 
suspended DMEM. The co-culture systems were than treated with varying concentrations 
of nanomaterial for 4 hours. After 4 hours of treatment, DMEM was removed, serial 
diluted in 1x PBS and plated on TSB agar plate to determine the bacterial viability. A 96-
well plate containing mammalian cells was than washed with 1x PBS and cell viability 
determined using Alamer blue assay. 
4.4.11) Co-culture of biofilm with mammalian cell 
Approximately 3 x 104 HEK 293 cells were pre-seeded in a 96-well plate. The 
mammalian cells were grown in humidified atmosphere in 5% CO2 at 37 °C for 24 hours. 
The mid-logarithmic growth-phase culture of Pseudomonas aeruginosa (ATCC- BAA 
2113) was centrifuged, washed with 1x PBS and re-dispersed in DMEM. The bacteria 
suspended DMEM were then added to the mammalian cells in the 96-well plate, and the 
plate was grown in a humidified atmosphere in 5% CO2 at 37 °C for 24 hours. After 24 
hours, DMEM was removed and each well was washed with DPBS multiple times to 
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remove the planktonic bacteria and protein debris. After washing, varying concentrations 
of nanomaterial were added, and the plate was incubated for 6 hours at 37 °C. After 
incubation, supernatant was collected, and the plate was washed with DPBS. For 
bacterial viability determination, the 96-well plate was bath sonicated for 10 minutes, 
serial diluted in 1x PBS and plated on TSB agar plates. The TSB agar plates were 
incubated for 12 hours and colony was counted. For mammalian cell viability, the 
collected supernatant was analyzed using Pierce LDH assay kit (Thermo Scientific) 
following manufacturer’s instruction. 
4.4.12) SEM and TEM analysis of bacteria  
For TEM, samples were initially fixed with 2.5% glutaraldehyde overnight at 4 
°C and pelleted into 0.8% uranayl acetate to form dense cell aggregates. The cell pellet 
was treated for 2 hours with 1% Osmium tetraoxide in DPBS, followed by washing with 
deionized water and then block-stained overnight at 4 °C with aqueous 0.5% uranyl 
acetate. The cell pellet was dehydrated in series in a graded acetone series. The sample 
was sectioned and post stained using 2% uranyl acetate in 50% ethanol solution and 
Sato’s lead citrate for 3-4 minutes. Images were acquired using Phillips CM-12 TEM 
operated at 80 kV using a Gatan model 791 side-mount CCD camera 
For SEM, samples were initially fixed using 2.5% glutaraldehyde at 4 °C, 
followed by washing with DPBS. The samples were postfixed with 1% osmium 
tetraoxide in DPBS, followed by washing with deionized water and dehydration in 
graded ethanol series. The samples were critically dried, sputtered coated with gold-
palladium and images was captured using JEOL JSM6300 SEM operated at 15 kV. 
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4.4.13) Propidium iodide staining assay for determination of bacterial damage 
The mid-logarithmic growth-phase culture of Staphylococcus aureus (ATCC-
BAA 1720) and Acinetobacter baumannii (ATCC- BAA 1797) was centrifuged, washed 
with 1x PBS and re-dispersed in MEM medium. The MEM culture of bacteria was 
treated with varying concentrations of nanomaterial for 2 hours. After incubation, 
bacteria were centrifuged and washed with 1x PBS. After washing, bacteria were stained 
with 1 µg/ml of propidium iodide (Sigma Aldrich) for 10 minutes on ice. The stained 
bacteria were than analyzed using Stratedigm S1300EXi cell analyzer equipped with 
A600 high-throughput autosampler. 
4.4.14) Membrane potential assay 
The membrane potential of bacteria was determined following the manufacturer’s 
protocol, Baclight membrane potential kit (Invitrogen). Briefly, bacteria were grown to 
mid-log phase and diluted to ~106 CFU/ml in 1x PBS. The bacteria were treated with 
different concentrations of MoSe2/PLL/F77 (1x MBC, 0.5x MBC, 0.25 x MBC and 0.125 
x MBC) for 2 hours. A fully depolarized sample was prepared with addition of 5 mM the 
proton ionophore, carbonyl cyanide 3-chlorophenylhydrazone (CCCP). After treatment, 
samples were incubated with 30 mM DiOC2 for 1 hour. Membrane potential was 
determined using a Stratedigm S1300EXi cell analyzer equipped with A600 high-
throughput autosampler using the ratio of cells exhibiting red fluorescence to cells 
exhibiting green fluorescence. Cell populations were gated based on untreated (polarized) 
and CCCP treated (depolarized) one. 
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4.4.15) LPS incubation assay 
MoSe2/PLL/F77 was incubated with LPS of E. coli O111:B4 in MEM medium 
for 1 hours. The mid-logarithmic E. coli cells in MEM medium was than incubated with 
MoSe2/PLL/F77-LPS mixture for 2 hours at 37 °C at 200 rpm. After incubation, bacteria 
were serial diluted in 1x PBS, plated on LB agar plates and plate was incubated for 12 
hours at 37 °C. The colony was counted, and cell viability was determined. 
4.4.16) Resistance study  
Staphylococcus aureus (ATCC-BAA 1720) and Acinetobacter baumannii 
(ATCC- BAA 1797) was inoculated in TSB medium and cultured overnight at 37 °C at 
200 rpm. The overnight culture was further diluted in TSB medium and incubated with 
MoSe2/PLL/F77 or antibiotics solutions in TSB medium. The plates were sealed and 
incubated for 16 hours. The MIC was determined. The bacteria from 0.5x MIC 
concentration of MoSe2/PLL/F77 or antibiotics were further diluted in TSB medium and 
treated with fresh solution of MoSe2/PLL/F77 or antibiotics and incubated as above. This 
process was repeated for 20 passages. 
 
 
 
 
 
 
 
 
86 
Chapter 5 
Summary and Future Outlook 
5.1. Thesis Summary 
In conclusion, this thesis demonstrates the development of two novel 
biocompatible, two-dimensional material-based inorganic hybrid systems for combating 
multidrug-resistant bacteria. We also demonstrated unique generalizable techniques for 
interfacing biological molecules with two-dimensional materials. 
In Chapter 3, I demonstrated solution-phase processing of TMDCs in the presence 
of one of the most important building blocks of biology, single-stranded DNA. To my 
knowledge, this is the first report demonstrating dispersion of TMDCs using short single-
stranded DNA. Furthermore, we screened the affinity of different DNA sequences with 
respect to TMDCs and identified T20 as the best sequence for dispersing the TMDCs. 
From our studies we concluded that MoSe2 has strongest affinity for DNA, with a 
dispersion efficiency as high as 1 mg/ml. Further, computational studies showed proper 
stacking of T20 with hexagonal crystal structure of TMDCs as a key factor towards the 
high dispersion efficiency of T20 compared to other DNA sequences. Further microscopic 
analysis of DNA-encapsulated TMDCs, showed a thin nanosheet morphology, which 
further showed efficient exfoliation of TMDCs in the presence of single stranded DNA. 
After successful characterization of nanosheets, we further demonstrated the antibacterial 
activity of MoSe2/T20 towards multidrug-resistant bacteria and ‘ESKAPE’ strains. 
MoSe2/T20 successfully eliminated all the ‘ESKAPE’ strains at concentrations as low as 
75 µg/ml. Mechanistic evaluations of the antibacterial action of MoSe2/T20 
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three-step pathway: first, sharp edges of nanosheet pierce through the bacterial membrane 
like a ‘nanoknife’ causing breakdown of cellular membrane; second, he damage to 
cellular membrane in turn triggers depolarization of the membranes followed by 
generation of oxidative stress; and finally, programmed cell death.  
In Chapter 4, I demonstrated a novel positively charged inorganic nanomaterial-
based nanohybrid system. The nanohybrid systems contains three components: PLL, 2D 
MoSe2 and Pluronic-F77. The PLL provides strong electrostatic force of attraction 
towards the negatively charged bacterial cell membrane, whereas Pluronic-F77 provides 
stabilization to the systems in buffer systems. Compared to PLL alone, the hybrid 
nanosystems exerts stronger electrostatic force of attraction and higher antibacterial 
efficiency. Furthermore, MoSe2/PLL/F77 successfully eradicated all the strains of 
multidrug-resistant bacteria from the ‘ESKAPE’ family, at a concentration as low as 25 
µg/ml. The non-specific antibacterial activity of MoSe2/PLL/F77 eliminates the 
traditional problem of ‘one bug-one drug’ approach. Mechanistic evaluations of 
antibacterial action of MoSe2/PLL/F77 demonstrated the electrostatic attraction between 
the PLL present on MoSe2 nanosheets and the negatively charged bacterial cell 
membrane led to rupture of the membrane. LPS incubation assays provide further 
evidence of the strong electrostatic force of attraction as a key mechanism towards 
antibacterial activity. Furthermore, resistance development comparison of S. aureus and 
P. aeruginosa with respect to MoSe2/PLL/F77, antibiotics and PLL, showed no resistance 
development of MoSe2/PLL/F77 after 20 passages, whereas bacteria developed 
significant resistance to both antibiotics and PLL after 10 passages. 
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5.2. Future outlook 
5.2.1 Towards antibacterial coating material for combating multidrug-resistant 
bacteria 
Nosocomial or ‘health care associated infections’ are one of the most critical 
problems in healthcare. Immune-compromised patients admitted into hospitals, which 
includes intensive care units, burn units and those undergoing organ transplantation are 
highly susceptible to these nosocomial infections. Furthermore, bacteria colonize on 
abiotic surfaces such as medicals implants causing additional surgeries and imposing a 
serious burden to healthcare providers. Conventional approaches to treat these infections 
involve the administration of antibiotics, but these interventions are not always 
successful. Additionally, most of the antibiotics available on the market are ineffective 
against multidrug-resistant bacteria and biofilms.  
Our two novel antibacterial materials systems, MoSe2/ssDNA and MoSe2/PL/F77 
can eradicate multidrug-resistant bacteria, biofilms and persisters using alternative 
mechanisms. The MoSe2/ssDNA materials can be incorporated inside biocompatible 
polymer coatings such as polyvinyl chloride and used for coating surgical instruments. 
The presence of negatively charged MoSe2/ssDNA on these coatings will likely inhibit 
the growth of biofilms on these surfaces. Other applications will involve vertically 
aligned depositions of nanomaterials on medical surfaces, which will eliminate the 
bacteria using sharp edges and act as a bactericidal coating. The other potential 
applications of DNA-encapsulated TMDCs are related to biosensing. The TMDCs 
surface can be augmented using functional DNAs such as biotinylated DNA which can 
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be further used for detections of potential biomarkers using fluorescence or microscopic 
techniques.  
The other antibacterial system, MoSe2/PL/F77, systems holds great potential for 
its applications as a bactericidal material. The strong affinity of these materials towards 
negatively charged bacterial cell wall opens up a wide range of applications towards 
elimination of multidrug-resistant bacteria. The potential applications in this regard will 
involve coating of medical equipments such as catheters, which in turn will inhibit the 
growth of biofilms and put an end to infections caused by these drug-resistant bacteria. 
Other potential applications will be in the field of therapeutics. The MoSe2/PL/F77 can be 
incorporated into base creams such as hypromellose and used it for the treatments of 
chronic infections caused by MRSA and P. aeruginosa for burn victims and those with 
other wounds. Furthermore, this material can be used for designing diverse 3D imprinted 
surgical implants when integrated with suitable printable materials. 
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Supplementary Information 
Chapter 3  
Elimination of Multidrug Resistant Bacteria by Transition Metal Dichalcogenides 
Encapsulated by Synthetic Single-Stranded DNA 
Cell viability of MoSe2/T20 
Figure A1 shows the biocompatibility of MoSe2/T20 tested on human carcinoma 
cells, HeLa cells and determined using MTT assays. The cellular viability studies showed 
100% cell viability at all the tested concentrations, with a concentration as high as 250 
µg/ml. 
 
Figure A 1: Biocompatibility study of MoSe2/T20 tested on human carcinoma cells, HeLa 
at a concentration ranging from 0 to 250 µg/ml. 
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Bacterial viability in different medium  
Figure A 2 shows, E. coli K12 MG1655 viability determined in four different 
media, minimal essential medium (MEM), 1x PBS, M9 medium and water. The 
overnight bacterial culture was centrifuged, and re-dispersed in four different medium 
and bacterial viability was determined using colony counting method. The bacterial 
viability shows no significant effect of medium on cellular viability after 4 hours 
incubations. 
 
Figure A 2: Bacterial viability of DH5a after incubations at four different medium, water, 
1x PBS, 1x MEM and 1x M9. 
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Zeta potential of four different TMDCs dispersed in single-stranded T20 
Figure A 3 shows, the stability of TMDCs dispersed in T20, determined using zeta 
potential. The zeta potential of MoSe2/T20, WSe2/ T20, MoS2/ T20 and WS2/ T20 was -42.1 
mV, -39.8 mV, -21.3 mV and -19.8 mV. Based on zeta potential, MoSe2/T20, WSe2/ T20 
was most stable whereas MoS2/ T20 and WS2/ T20 was least stable.  
 
 
Figure A 3: Zeta potential of TMDCs dispersed in synthetic single-stranded synthetic 
DNA sequence T20 
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Thermogravimetric analysis (TGA) of MoSe2 dispersed in T20 
Figure A 4 shows the amount of DNA present on the surface of MoSe2, which 
was analyzed using TGA. The TGA analysis of MoSe2/T20 showed presence of 8% DNA 
on the surface of MoSe2. 
 
 
Figure A 4: Thermogravimetric analysis of MoSe2 dispersed in single-stranded T20.The 
TGA curve shows the change in weight with respect to temperature, showing degradation 
at 500 °C. 
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Microscopic evaluation of antibacterial activity of MoSe2/(GT)10 
Figure A 5 shows, the change in morphology E. coli, K12 MG1655 of 
MoSe2/(GT)10, after interactions with nanosheets. SEM images of bacteria demonstrates 
change in bacterial morphology after interaction with MoSe2/(GT)10 nanosheets. The 
SEM images shows formation of small blob like structure on cell membrane after 
interaction with 0.5x MBC of MoSe2/(GT)10 nanosheets and it shows broken cell 
membrane at 1x MBC. The TEM images of bacteria shows no change in cytoplasm for 
control samples, whereas it shows change in cytoplasm at 0.5x MBC and 1x MBC 
 
 
Figure A 5: Microscopic evaluation of E. coli (a, c, e) SEM images of E. coli after 
interactions with MoSe2/(GT)10 nanosheets (b, d, e) TEM images of E. coli after 
interactions with MoSe2/(GT)10 nanosheets. 
 
 
 
114 
APPENDIX B 
SUPPORTING INFORMATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
115 
Supplementary information 
Chapter 4  
Eradication of multidrug-resistant bacteria using two-dimensional material based 
nanohybrid structures 
Zeta potential of MoSe2/PL and MoSe2/PLL/Pluronic-F77 
Figure B 1 shows, the change in zeta potential from MoSe2/PL to MoSe2/PL/F77 
structure. The zeta potential changes from +41.4 mV to +21.4 mV, which clearly shows a 
formation of hybrid structure of MoSe2, PLL and Pluronic F77 
 
Figure B 1: The zeta potential measurement of MoSe2/PL and MoSe2/PL/F77. The 
change in zeta potential clearly shows the replacement of PLL with Pluronic-F77 
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Thermogravimetric analysis of MoSe2/PLL/Pluronic-F77 
Figure B 2 shows, the thermogravimetric analysis of MoSe2/PL/F77 systems to 
determine the content of polymer with respect to MoSe2. The TGA analysis demonstrates 
22% polymer on the surface of MoSe2. 
 
Figure B 2: Thermogravimetric analysis of MoSe2/PLL/F77 systems. The TGA curves 
shows degradation at 300 °C. 
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Antibacterial activity of MoSe2/PLL.F77 against model systems  
Figure B 3 shows, the antibacterial activity of MoSe2/PL/F77 determined against 
two model systems, gram-negative E. coli K12 MG1655 and gram-positive S. aureus. 
The MoSe2/PL/F77 eliminated both strains of bacteria at 50 µg/ml. 
 
Figure B 3: The antibacterial activity of MoSe2/PL/F77 determined against two model 
systems, gram-negative E. coli and gram-positive S. aureus.  
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AFM characterization of MoSe2/PL/F77 
Figure B 4 shows, the thickness of MoSe2/PL/F77 system, characterized using 
AFM. The thickness of the flake was ~ 8 nm. 
 
Figure B 4: The AFM image of MoSe2 /PLL/F77, which shows thickness around 8 nm. 
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SEM image of PLL resistant S. aureus 
Figure B 5 shows the change in morphology of S. aureus after 10 passages with 
PLL. The SEM images shows formations of flagellar like structure on the surface of S. 
aureus membranes, which inhibit the interactions with PLL. 
 
Figure B 5: SEM images of S. aureus before treatment and after 10 passages of treatment 
with PLL. 
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TEM imaging of TSB medium before and after treatments with PLL 
Figure B 6 shows, the secretion of small vesicles in the medium, which provide 
resistance to S. aureus from PLL. 
 
Figure B 6: TEM image of bacteria cultured medium for S. aureus showing the secretion 
of small vesicle like structure in medium, as a part of resistance mechanism of PLL-
resistant bacteria. 
 
 
 
 
 
 
